var title_f6_12_6336="Measurement QT dispersion";
var content_f6_12_6336=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F79885&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F79885&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 485px\">",
"   <div class=\"ttl\">",
"    Measurement of QT dispersion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 465px; height: 380px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAF8AdEDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKK57xt4v0rwbpkV5q7ys08qwW9rbp5k9zIxwEjQcsea4E6D4y+JkcD+LJ5vCvhiQF/7JsJmW9uVIwFuJP4VwTlAO+DzggA3NW+LXh+31SbS9Fh1HxFqkMgikttJtzLsYlgQ0hwikbTwWqgfFvxK1WD/iTfD6100TS7YbrVtUU+Um/G+WBFDfdBO1WPXjPfvvDXh/SvDOkw6ZoNjFZWUIwsceT75LHJY5J5JJOa1KAPLv7a+LOkyyjUPCvhzXojGHRtL1B7TYRnKsJgxYnjGAPx7avhT4o6DruoDSr0XOh6+OH0zU08mXOSvyE/K4JHBU+n0rvKwPGXhDRPGOlSWGv2ENwjKRHNtAlgbs0b9VYeo/HIyKAN+ivIYfEfiP4YSraeOprjXfC5eKOHxGqKJLUEbdtyg5I3AfvOSd3JJOK9bgljnhjmgkSSKRQ6OjAqykZBBHUGgB9FFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXNePfGOn+C9F+234knuJnENnZQDdNdzH7sca9SScfSjx54x03wZo63moeZNczuIbOygG6a7mP3Y0XuScc9q5vwB4N1G41pvGnj0pP4mnXba2YO6HSYT/AMso/Vz/ABP+A7kgC+AvB2pXGtDxn4+Mc3ieVCtrZod0GlQn/lnH6uR95/qBxyfSKKKACiiigAooooAivLaC9tJrW7hjntpkMckUihldSMEEHqCK8hikvPgxqMdvctLd/De6l2xTsS8miyMeEfu0BJ4P8PQ9t3sdQ3lrBfWk1reQxz20yGOSKRQyupGCCD1BoAfDLHNCksLrJFIoZHQ5DA8gg9xT68d0advhH4rXQ9Rupx4B1I/8Su5uPmXTrgk5tmkzkRnqpYd8Z4JPsVABRRRQAUVm6Lq8Or/b/IjkT7HdyWb78fMyYyRjtzWlQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVk+K/EFh4V8O3+t6xI0djZx+ZIUUsx5AAA9SSAPr2rWrx2P/i7fjpmYRyeBPDd0DHlGZNVvApBPI2mOM5HGcnuQeADR+G3hi/1fWZfHnje2kXXLguumWU/TS7Q/dUL0ErD7x6844ywr1GiigAooooAKKKKACiiigAooooAyfFfh+w8VeHb/RNYjaSxvI/LkCMVYcggg+oIBH071xfw017VdP1+/wDAni64lu9W0+MT2GoSRlTqFnwA7HJBdSQrc5PXk5NelVwnxY8GSeJtKh1DRHSz8V6U32jTL7kFWHLRsV5KOMqRz1zg9KAO7orlfht4xtvGvhqG/jVbfUI/3N/YknfaTjho2BAI5zjI5FdVQByXw8/5mb/sN3P/ALLXW1yXw8/5mb/sN3P/ALLXW0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUVyvxL8XR+DPDEl8IHutRuJFtNOtEQs1zdPny48DsSOfYHHOAQDmPilruoazrMHw98JTSw6zfRLc397FKE+wWW8B2zgnewO1QBkbgcjiu+8M6Fp3hnQbLRtFt1ttPtE2RRg5xySST3JJJJ7kmub+Fvg+Xw1pt3f6vItz4m1mQXmqXHlov7wjiJdv8CcgDJGcnvXb0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAeSfEC1n+H/i8/ETSYp5dJuEWHxJaRSD541wsVwqkcsmTkAjIx0yxPqtlcw3tnBdWkqTW88ayxSIcq6sMgg9wQafPDFcQSQ3EaSwyKUeN1DKykYIIPUEV5P8KjP4G8VX/wAOL9t9iok1LQp8N81szkvATtwWjY5znkN26AA674ef8zN/2G7n/wBlrra5L4ef8zN/2G7n/wBlrraACiisjxNqz6PbWMscSyG4vre0IY4wJZFQn6jOaANeiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAryDwgD8TfiA/i+5Vj4Z0GWS00SNnUrPOCVlusAcr0C5J6Z4NaHxj1W81O50zwB4fult9W18N9puFf57OzX/AFkgAIOW+6PX5vSu/wDD+j2Hh/RbPSdIt0trC0jEUUSDgAfqSTkknkkknmgDQooooAKKKKACiiigAooooAKKKKACiiigAooooAK4H4w+EbrxHoVvqHh8RxeKtGmW90yc4BLqctESQflcZGDwTjPGa76igDzr4Ga4viXwtqWtJbS2ovdVuJfIl+/EcqCp+hB/+t0r0WvAPDmqTeAfijrN5ckJ4Q8R6xLYnaQqWV+uCrEEgASLvyQOoGenPv8AQBw2oarfR/GnR9KS5kGnS6Jc3D24PytIs0QDH3AJH41f+In/ACD9H/7DVh/6UJWhPZaI3jC0vZmg/wCEhSzkigUzkSG3LKXxHnBG4LlsccDPNZ/xE/5B+j/9hqw/9KEoA6qiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACsnxX4gsPC3h6+1nV5lhs7SPezN3PRVHqSSAB6mtavItVLfE/4kLpELt/wiHhe4We+dVUi81BTlIc5OUUHLcdRj+6QAafwX8PXsdne+MPEsbDxP4jKz3Cum020IGIoACoIwm3IPUjnOM16VRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHnOm+HrLxX4Z8b6JqaK1te6rdxElQxQ/LtcZ7qcEe4pfg34ivLuw1Dwv4h2DxH4akSyuiuQLiLb+6nXKjh1B/LPGRWx8PP+Zm/wCw3c/+y1y3xf0+48OatpvxG0O08650gNHq0MRVXurFh838J3MhAYZIwM0AaGp/8nA6D/2L93/6Pirc+In/ACD9H/7DVh/6UJVWHSG1nx9ofjPT7q2l0j+xpIEwTvk8145EdeMbdq+ueRxVr4if8g/R/wDsNWH/AKUJQB1VFcZb67qD/GO90FpgdLj0OG9WLYMiVp5ELbsZ+6o4zjiuzoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKK4P4zax4h8N+DLzXfDd1YRf2fE008V3bNL5w4ACkMu3vzzXFzeO/G2h65o8V7Da6+LrRJ9VktbGNLQAKUIJaRmPygsODySOO9AHuFFeaaX8VodV1Cyg07Qr+aCbS7fV57jzYlW1t5N2S4LAkrtPC7ie1YunfHW3vdO1C+XwxqzW8Nj9vtjBiUzJ5iptbAwjYcOeWAUMc8YoA9lorxA/FrV9X1Twg/hzTYLpL+7vrafT7a9hl+0eVbCRP3rAeXgtkggHC9DkZ0IvjbBd6NbX2m+Hb25caXPrF9CZ0Q2tvDM8LkE/fbdG+AMZAzx0oA9forx5virJZa54vnkjl1DTYI9I/sm0iVY3kkvEYhSx6ZO05PQA/Sui+FXiTWfEN54tj16JIJdP1Q2sVuhVvJTykbbvAG7ljzQB39FeDeH/jZc2ngbwzLqenzaz4gv7CbUJxCVhXykmaMYwDliQAFA7ckV1afF2xk1a30xNJvlv7qewjtoJCEeWO6jMglwegQK4cdiuPSgD06ivGV+NUerrqcOkaTeRRG0vnsdQOHXzLeNzmRMfICUbbknOMEDNekeANSudY8B+G9Tv3El5e6bbXMzhQoZ3iVmOBwOSeKAN6iiigAoopGYKpZiAoGSTwAKAOF+MHiq88OeGhaaBFLceKNXY2WkwxJuPnEcyHI2gIpLEtxxzxmtj4feFoPB3hW00mCWSeVcy3NxK5d5535kkJPPLZNcP8ON3xA8b3fxCuUjGkWgl0zQUKkl4w5El1kgYLkYAxkDIPTn1ugAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDkvh5/zM3/Ybuf/AGWupuYIbq3lt7mKOaCVDHJHIoZXUjBUg8EEcYrlvh5/zM3/AGG7n/2WutoA8G+H0mseB/jXL4BlvgnhKS0uL3SIJBy251YRK75J8seYNqnoCx9vT/iJ/wAg/R/+w1Yf+lCV5f8AHDw9res/FHw/eeGHePWNJ0qbULM52pLJHNHmJmxj5kZxg4ByAcDNdfP4rsfGngXwzrenfIk+sWAkhZgzwSC4TdG2OhB+nGDjmgCW1B/4aH1E9v8AhGLf/wBKpa9GrFj8R2knjObwyI7j7fFYJqDSFR5RjaRkABzndlT2xjvW1QAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBz/i+2ttW0fVdJ1PR7rUdPlsy8kcT7fP5P7pSGDBuAew561RvNC0s6klw2gXUs1rCujQyrMQDayhN5A3/dXoSRu+U4rrqKAON8OeHdH0S/tZNL8O3Vq7WzaV5jzF1jtoGbywwZzkN1U43EMN1YkHgXw3BplwLfwpqsUc1itx9kS/lVY2Zw5hjUS7YpAyKcptHTBrsvF/inRvB+jnVPEd6LKwEixeaY3k+ZugwgJ7elcR/wv/4Zf9DOv/gFc/8AxugDY0zwd4e0bU7S40/w3di506/doLk3DuzNPEqyzszSEyDadp35I28DoapH4d+E7m006wl8KXSWtv8Aa4UxcyLtj85nKyMJNzxyMS4Vtw55A6VU/wCF/wDwy/6Gdf8AwCuf/jdH/C//AIZf9DOv/gFc/wDxugDT1DwxoWoWesTXnhK6c6rZWc13Csu1naLcI4VAcBHj9V29Rya0vDWi6d4Sa/t9B0S+iS61BPPla4aYzFo0zPukcttH3T3yp4PWua/4X/8ADL/oZ1/8Arn/AON0f8L/APhl/wBDOv8A4BXP/wAboAuL4D8MyWGjaavhe+trfT1uorWSK8kikt0Eh+UypIHKyZLAFjx1x0q4nh7Ro9W0zX18K3f9saTpcUVnJ5mXjRg6mDl8F0BOS2fvcHrWP/wv/wCGX/Qzr/4BXP8A8bo/4X/8Mv8AoZ1/8Arn/wCN0AaY8DeG4NUvZYfDl6n2m5kt5BFdyrbss0P72YRCQIoIdkJChs5x2NdDorLpel6fpun6PeW9jawSQQxlg3lRwEJGpJYk71AKkk8DnBri/wDhf/wy/wChnX/wCuf/AI3R/wAL/wDhl/0M6/8AgFc//G6AO8fVrlbZ5RpF8zLbwzCMbNzM5YNGPmxuTALdvmGCalfUJ1uTENNumUXQt/MG3bsMYfzev3ATs9cg8Y5rz7/hf/wy/wChnX/wCuf/AI3R/wAL/wDhl/0M6/8AgFc//G6AO/j1O4YJu0q8Usk7kfJwY3Cqv3urg7l9hzivMPjT4q1W7g0/wP4fsLmLW/EcC75CVJtbZtwmbCsCWUDnkA7jgnBxff8AaA+GaoxHiUMQMhRZXGT7cx1518Nvi74JfxHrfjPxf4gFtreogWdtZG1uHFjZxsdqAqGUlzhzjv8AU0Ae86BDFoWm2Oi6bpVzFYWTpYREYwI1iDCXlslc/KSed2frVtNUuGiVzpV6pMU8m07MgxsFVOvVwSV7YBziuB/4X/8ADL/oZ1/8Arn/AON0f8L/APhl/wBDOv8A4BXP/wAboA71tUuQjMNJvGIjgkCgpyZGKsv3uqAbm9iMZqVdQnNyIjp10F+1G38z5duzy9/m9fuZ+T1z2xXnv/C//hl/0M6/+AVz/wDG6P8Ahf8A8Mv+hnX/AMArn/43QB3q6rcGBZDpN6rGCaYodm4NGwCxnDfecEle2AckUsuqTpvxpV6+1YG42cmRyrAfN1QDc3seM1wP/C//AIZf9DOv/gFc/wDxuj/hf/wy/wChnX/wCuf/AI3QB6EmoTNcLEdPulU3TW/mHbtCiMv5vX7hI2euSOMc1ANWuTarL/Y99va2mn8v5NwZCAsR+b7z5JHbg5IrhP8Ahf8A8Mv+hnX/AMArn/43R/wv/wCGX/Qzr/4BXP8A8boA9Ak1G4R5FGmXbhfIwVKfN5j7Wxz/AAD5m9umacl/M06xnTrpVa6a33nbgKELCXr9wkBR3yRxjmvPf+F//DL/AKGdf/AK5/8AjdH/AAv/AOGX/Qzr/wCAVz/8boA7r+2Ln7Is39jX+82ktyYjs3BkIxF97G9snHbg5IqeXUZkllVdNu3CNAAw24YSPtYjn+AfM3t0zXn3/C//AIZf9DOv/gFc/wDxuj/hf/wy/wChnX/wCuf/AI3QB6FHqE7zpGdOulVrp7cuduFVUZhKefukqFHfLDiq41e6+xrMdGvg5s3uTFlNwdcYh+999s8duOtcL/wv/wCGX/Qzr/4BXP8A8bo/4X/8Mv8AoZ1/8Arn/wCN0AehTahPHNMi6ddOsbwIrrtw4kYKzDnogOWz2Bxmki1GZ5okOnXaB7mSAu23CqqsRKefusVAHfLDIFeff8L/APhl/wBDOv8A4BXP/wAbo/4X/wDDL/oZ1/8AAK5/+N0Ad1/bFz9iE40a/wB5smu/J+TcHAH7j72N5zx2461Yl1CdJ7iNdOunWKWGNXXbiQOQGcc9EyS2eeDjNee/8L/+GX/Qzr/4BXP/AMbo/wCF/wDwy/6Gdf8AwCuf/jdAHoMWoXDzQo2m3SK9xLCXYrhFTdiQ8/dbaMd/mGQKg/te6+yed/Y1/v8AsJu/K+TdvxnyPvY8z9PeuF/4X/8ADL/oZ1/8Arn/AON0f8L/APhl/wBDOv8A4BXP/wAboA1/A17LDJ4qVLG5mCeIZIgybcMH8vc4yeibjn/dOM11UOozSTQI2nXaCSaaJnbbiMIW2uefuvgYxz8wzivG/Bnxu+Hmn/279s8RLH9p1We4i/0S4O6NtuG4j74PWuj/AOF//DL/AKGdf/AK5/8AjdAHTz+Mkh1mz0ltKvv7RutJk1VbcbNw2FQYTzjfl8dcZHWvKfHtldeCfiHHqsCPaeDNW1iyfUWmceVDdq6SfaV4JVGC7GyQN3J421Bf/GTwFL8YtJ1uPX1OmQaNcWsk/wBln+WVpY2VcbMnIUnOMcVc+JHxg+GfiXQINMbXYru2kvrZrmJ7KfBhEqlz80eDgZP4UAdLpWpSXH7Rl4psLlEk8OKgkO0qFS7lCuSD91xyuMnkZA5x351i5Fk0/wDY1/5gsluvJ+TcXOf3H3sbxjntz1r5t+EPxM8EeGPEWppr3iKef7Bappel6l9nkMU9grF4kZFjDCVdxBJABA46ZPrH/C//AIZf9DOv/gFc/wDxugD0GXUZkmlQadduEuY4A67cMrKpMo5+6pYg98qcA0sWoTySwodNu0EjzoWOzCCNiFY89HAyuOxGcV57/wAL/wDhl/0M6/8AgFc//G6P+F//AAy/6Gdf/AK5/wDjdAHdHV7r7G0w0a+LizS5EWU3F2zmH7331xz2561Yk1CdJ3jGnXTKt0luHG3DKyKxlHP3QWKnvlTxXnv/AAv/AOGX/Qzr/wCAVz/8bo/4X/8ADL/oZ1/8Arn/AON0AegxajM8sStpt2gdpwWO3CiN9qk8/wAY+ZfbrioRq9z9kaY6Pf7xaxXHlfJuLOTmL72N64Ge3IwTXCf8L/8Ahl/0M6/+AVz/APG6P+F//DL/AKGdf/AK5/8AjdAHoUmoTJO0Y066ZVultw67cFSgYy9fuAkqe+QeMc02PUbh3jU6ZdoG8/JYp8vlvtXPP8Y+ZfbrivP/APhf/wAMv+hnX/wCuf8A43R/wv8A+GX/AEM6/wDgFc//ABugDuzq10LVpf7Hvi4toZ/KGzcWckNH977yYBbtyME1O+oTLcNENPumUXS2/mDbtKmMP5vX7gJ2euQeMc157/wv/wCGX/Qzr/4BXP8A8bo/4X/8Mv8AoZ1/8Arn/wCN0Ad+mpzsUzpd4u5J252fKY2CqDz1cHcvsOcU1tVuBA0g0m9ZhBDMEGzcWkYhoxlvvIAC3bBGCa4L/hf/AMMv+hnX/wAArn/43R/wv/4Zf9DOv/gFc/8AxugD0I38/wBpMQ0652i6Fv5ny7dvl7/N6/dz8nrntjmtCvLf+F//AAy/6Gdf/AK5/wDjdeg+HtasPEWi2mraPcfadPuk8yGXYyblzjOGAI6dxQBo0UUUAFFFFABRRRQBW1HT7PU7f7PqVpb3cGQ3lzxLIuR0OCMZrM/4RDw1/wBC9o//AIBRf/E1uUUAYf8AwiHhr/oXtH/8Aov/AImj/hEPDX/QvaP/AOAUX/xNblFAGH/wiHhr/oXtH/8AAKL/AOJo/wCEQ8Nf9C9o/wD4BRf/ABNblFAGH/wiHhr/AKF7R/8AwCi/+Jo/4RDw1/0L2j/+AUX/AMTW5RQBh/8ACIeGv+he0f8A8Aov/iaP+EQ8Nf8AQvaP/wCAUX/xNblFAGH/AMIh4a/6F7R//AKL/wCJo/4RDw1/0L2j/wDgFF/8TW5RQBh/8Ih4a/6F7R//AACi/wDiaP8AhEPDX/QvaP8A+AUX/wATW5RQBh/8Ih4a/wChe0f/AMAov/iaP+EQ8Nf9C9o//gFF/wDE1uUUAYf/AAiHhr/oXtH/APAKL/4mj/hEPDX/AEL2j/8AgFF/8TW5RQBh/wDCIeGv+he0f/wCi/8AiaP+EQ8Nf9C9o/8A4BRf/E1uUUAYf/CIeGv+he0f/wAAov8A4mj/AIRDw1/0L2j/APgFF/8AE1uUUAYf/CIeGv8AoXtH/wDAKL/4mj/hEPDX/QvaP/4BRf8AxNblFAGH/wAIh4a/6F7R/wDwCi/+Jo/4RDw1/wBC9o//AIBRf/E1uUUAYf8AwiHhr/oXtH/8Aov/AImj/hEPDX/QvaP/AOAUX/xNblFAGH/wiHhr/oXtH/8AAKL/AOJo/wCEQ8Nf9C9o/wD4BRf/ABNblFAGH/wiHhr/AKF7R/8AwCi/+Jo/4RDw1/0L2j/+AUX/AMTW5RQBh/8ACIeGv+he0f8A8Aov/iaP+EQ8Nf8AQvaP/wCAUX/xNblFAHnPgLwt4fm/4SPzdC0qTZrNyi7rOM7VG3AHHA9q6r/hEPDX/QvaP/4BRf8AxNZ3w8/5mb/sN3P/ALLXW0AcfL4D8Gt4lt719G0pdQS2eJIBDGFaMspLGPGCQcDdjjOO9Znj/wAK+HobDSDFoOkoW1ixQlbOMZUzoCOnQjiman/ycDoP/Yv3f/o+Ktz4if8AIP0f/sNWH/pQlAHF2vhnQT8fdQtToml/Zh4bgkEX2SPYHNzIC2MYzgAZ9q9C/wCEQ8Nf9C9o/wD4BRf/ABNZcHh++T4u3niFlj/s2XRIbFTu+bzVnkcjHphhzXYUAYf/AAiHhr/oXtH/APAKL/4mj/hEPDX/AEL2j/8AgFF/8TW5RQBh/wDCIeGv+he0f/wCi/8AiaP+EQ8Nf9C9o/8A4BRf/E1uUUAYf/CIeGv+he0f/wAAov8A4mj/AIRDw1/0L2j/APgFF/8AE1uUUAYf/CIeGv8AoXtH/wDAKL/4mj/hEPDX/QvaP/4BRf8AxNblFAGH/wAIh4a/6F7R/wDwCi/+Jo/4RDw1/wBC9o//AIBRf/E1uUUAYf8AwiHhr/oXtH/8Aov/AImj/hEPDX/QvaP/AOAUX/xNblFAGH/wiHhr/oXtH/8AAKL/AOJrWs7W3sraO2s4Ire3jGEiiQIqj0AHAqaigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKK5Hx9480zwfFFDLHPf6zdKxstLtELzXBHsAdq56seBz16UAdXNLHDG0kzrHGvJZjgD8a8/1D40fD+xuHhfxHDOyKGZ7O3muowCM/fiRlz7ZyKydP+HGreLhDqXxV1aW8L4lXQLNvKsrf5twR8HMxHAJJxxj5sA16VpWjabpFl9k0uwtbS2wFMcMSqpAG0Zx14AHNAEHh7xJoviS2NxoGq2WowrwzW0yybTgHBweDgjg8jNa1eceK/hhby30WueBZ4PDHie3DBLm3gBhuFKgeVNGMBl4XnHBGcGtD4deN31+S50XxBaDSvF2nDF7YE/K69BNCf4om4we2cHsSAdvRRRQAUUUUAFFFFABRRRQByXw8/5mb/sN3P8A7LXW1yXw8/5mb/sN3P8A7LXW0AcleeHLyb4p6Z4jR4BYW2lT2TqWPmGR5EYEDGMYU96f8RP+Qfo//YasP/ShKrX2u38Xxe0nQkmUaZPo9xdyRbBkyLLGqndjPAY8dOas/ET/AJB+j/8AYasP/ShKAIYPEF8/xcvPDpMf9nRaJFfqNvzea08iHn0wo4rsK85tf+TiNR/7Fi3/APSqWvRqACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoorj/AIm+Mv8AhD9Ege0tlvta1CdbPTbHzFQzzOcDOSPlGQSR046ZzQBn/EXxvc6bqFt4X8JWy6j4x1BN0MLf6qzizg3E57IOw6seB1q18P8AwGnhq7vtY1fUJdb8U6hgXWqToFbYMYijUcJGMdB1PXoAF+HPg658Pi91XX79tT8Uarte/ugSI1252xRL2jXJA4yepx0Ha0AFFFFABXmXxm0XUrdNP8a+FYriTxBoLhnt4WOb2zLAzQFeQcj5hxnjjnFem0hAYEMAQeCD3oAzvDet2PiPQrHWNJlMtjeRiWJypUkH1B6EHitKvINGjT4afFlNCgXyPCXilGlsIgQIrS+Tl41Bb5VdTkAD720KOtev0AFFFFABRRRQAUUUUAcl8PP+Zm/7Ddz/AOy11tcl8PP+Zm/7Ddz/AOy11tAHnOp/8nA6D/2L93/6Pirc+In/ACD9H/7DVh/6UJWhP4js4PGFp4baOc31zZyXqOFHlhEZVIJznOXGOPXms/4if8g/R/8AsNWH/pQlAGhHrunv4xm0BUf+1IrFL1m2DaYWkZAN3XO5TxW1XnNr/wAnEaj/ANixb/8ApVLXo1ABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBBfXlvp9lPd308dvawIZJZZGCqigZJJPQV5Z8Mbe58c+J5/iNrEcsViVa28PWkj8wW/3ZJmUAfNIVyOT8p7jaaPiLJc+PfGsPw809podIto477xDcxsyboifktQwHBfhjgj5QfQivV4IkghjihUJHGoRVHQADAFAD6KKKACiiigAooooA4b4z+HLnxH4Duk0tEbV7CSPUbAsu4+dC24BcEEFgGXIP8VbfgXxJb+LvCOl65aZEd5EGZCMGNwdroR6qwYfhW9XkvgmL/hCfi/r3hWP93ouuR/23pqCLasc2ds8SkLg9FbGflG3jkkgHrVFFFABRRRQAUUUUAcl8PP+Zm/7Ddz/AOy11tcl8PP+Zm/7Ddz/AOy11tAHnOp/8nA6D/2L93/6Pirc+In/ACD9H/7DVh/6UJWhP4fsZvF9p4gd5f7RtrOSzRA42GN3ViSMZzlRznvWf8RP+Qfo/wD2GrD/ANKEoAvx+G7SPxpP4mEs/wBulsE09oyR5YjWRnBAxndlj3xjtW3XnNqT/wANDaiMnH/CMW5x/wBvUtejUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFc18RPFlr4M8KXerXQ8yZR5VpbDO65uGB8uJQATlj7HAyegrpa8khRviL8W1uyjHwz4NneKPdjbc6lgAsAV6Rgnv8AeAIoA6H4O+FZfDfhRZ9VAfxFqrG+1S4YfO8zkttJIBwobAHbmu6oooAKKKKACiiigAooooAK8z+PWmT/APCJxeKNKTOt+GZhqVqwTcWRf9bGcc7Smc/7temUjqroyOoZGGCCMgigCnomqWmt6PZappsoms7yFZ4XHG5WGRweR16GrteT/CRX8G+KNc+HlyX+yW5Op6KzBiDZyN80e4k58tzj3znvXrFABRRRQAUUUUAcl8PP+Zm/7Ddz/wCy11tcl8PP+Zm/7Ddz/wCy11tAHnOp/wDJwOg/9i/d/wDo+Ktz4if8g/R/+w1Yf+lCVBe6BfTfFnSvECLH/Z1vpFxZyMX+YSPLGyjHphTz7VP8RP8AkH6P/wBhqw/9KEoAq2+h6gnxkvdeaADS5NChslm3rzKs8jlduc/dYHOMc12lcnB4jvH+Kt34aMcH2CLRotQVwp8zzGmdCCc424UcYznvXWUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUVFdXENpbS3N1LHDbwoXkkkYKqKBkkk9ABQBw3xh8WXfh/Q7fTfDzofFWtSiz0yIgsQxIDzFQD8qKdxJGBxmtz4feE7HwT4TsdC00s8dupLzOBvmkY5Z2x1JP6ADtXEfCuG48a+KL74j6pvW2YSadoVsUChLMPzMRk/O7ZGfQdwRj1mgAooooAKKKKACiiigAooooAKKKKAPLPjXa3eiS6N8QNHjkkuvD8mL6FGb/SLBziVcDrt4fkYG0t2FemWF3Bf2NveWkgktriNZYnAI3IwBB556EUt7bRXlnPa3CK8E8bRyIwBDKwwQQeDwa82+Al21r4cv/CV55i6j4Zu3snSQLuMBZmgf5eoZO+BkqaAPT6KKKACiiigDkvh5/wAzN/2G7n/2Wutrkvh5/wAzN/2G7n/2WutoA5C98Q3sPxW0vw8nlf2fcaTPePlfn8xJY1GD6YY8VL8RP+Qfo/8A2GrD/wBKErD1P/k4HQf+xfu//R8VbnxE/wCQfo//AGGrD/0oSgDDtf8Ak4jUf+xYt/8A0qlr0asWPU9IbxjPpSKn9upYpcyN5PzfZzIyqN+ORuDfLn3raoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAryb4yahJ4l1bSPhvo02brVpBNqzxEk2tgmGbdtI2mQ4UZ6jI/iFema3qdpouj3uqalKIbKzheeaQgnaigknA5PA6Dk1wHwQ068udM1Hxlrcbx6v4mlF0Y3ZiYLZciCLkDopz/wKgD0e0t4rO0htrZBHBCixxoOiqBgD8qloooAKKKKACiiigAooooAKKKKACiiigAryT4mQv4J8d6T8RLOGVtOaP8As3xAsMYb/RycxzkAZOxgMnrgKOBnPrdVtTsLXVNPuLHUbeO5s7hDHLDIuVdTwQRQBPE6yxpJGQyMAykdwadXkXw/vL34eeI7T4ea/Mtxplwkknh/UWkwzxqcm2kDHO9NwC44K4AxjA9doAKKKKAOS+Hn/Mzf9hu5/wDZa62uS+Hn/Mzf9hu5/wDZa62gDFn1zTovGFpociMdVns5LuN/LGBErqrDd1HLDis/4if8g/R/+w1Yf+lCVh6n/wAnA6D/ANi/d/8Ao+Ktz4if8g/R/wDsNWH/AKUJQBh2v/JxGo/9ixb/APpVLXo1YMfhqGPx1P4nE8huJtOTTjDgbQqyNJuz1zlsfhW9QAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRXin/CTePo/HXiHQptW0MwaRp66i0kenOGkVg2EGZCARjqQR7U3wr8ZL2Lwzby+KdDuVuh4eOtpdJLFtvVTAfCr/qySQQD26gdKAPbaK8n134wtpFtpom8L366hfwyXcNpLcxAm3UKQ+5C4yxbAXrwc7aWP4y2s3irSNHTRri2F+lq4l1CdbUnz1BxGrDEhTOGAYHcCACcZAPV6K8M8CfGS+TQ9Hl8ZaXcGK+i1KZNViaLbKLQyu6iJTlcRpjJxkjpzmpPF3xe1FPA+vTWmmy6JrkOlW+sWJleO4WS2lmVAxwMBuoKkcZ6mgD2+ivHvHfxN1SHVJbHw5YNHa2Gt2WmXmoyuhDPIy741jIJPysBu4wenrXReO/Fl14d8eeErQziPR7q11O5vl8sMzLbwo6kHqMZbp1oA7+ivGrD46W9zpV/qMnhrUUtLazj1FXRw4a3aRUYkgYV1DqxTJ4zzxV/VPjNYWsG+y0ue7abU7jTbI+cqx3PkKGklD4OEHQcEk/nQB6tRXl3g3x/e+KfiBpVvFDPZaTeeHZdQayuYgJY7hLsQnJxnGN2OxGDXqNABRRRQAUUUUAFFFZXirXLTwz4c1HWtSYraWULTPgZJx0A9ycD8aAPOfiSp8eePNO+H0crjRoIhqWv+VJtLxgjyYCdpxuYBjgg7R24r1mNFjRUjUKigBVUYAA7CvPPgjod/ZeHLnX/ESsPEfiOb+0b0PuBiU/6qHDcgImBjtnHYV6LQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAYHjfwnpfjLQZdL1iJjGSHimjO2W3kH3ZI2/hYH/A5BIriPCnje98K6pH4Q+Jt1HHqGQmm6yw2Q6pHkAZPRZRkBgT3z7n1aszxHoOl+JdIuNL12yivbC4XbJFIOo9QRypBAIIIIIyKANOivHDbeJ/hEDJY/bPFHgSNHJs8KbvS1BLZRicyxgHGCSQFGMDOfT/DfiDSfE2lRaloOoW9/ZSYxJA4bacA7WHVWAIypwRnkUAY3w8/5mb/sN3P/ALLXW1yXw8/5mb/sN3P/ALLXW0AYk/hu0m8Y2niRpZxe21nJYpGGHllHdWJIxnOVHfHtVD4if8g/R/8AsNWH/pQlYepsf+GgNCXJx/wj93xn/pvFW58RP+Qfo/8A2GrD/wBKEoAx7W4mPx/1C3MsnkDw1A4i3HaG+0yjOOmcd69CribfRtQX40X2ttbkaXJoMNms+4YMouJGK4zn7pBzjHNdtQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAGBe+GdLW/1jWYdO8/Vb+y+yT/v2Xz41B2x9dq9cbgAea5u68EaU+nx2v/CJeZDbaTFpcMf9pOP3Er4mhzu/gCq288tnANYmt/EP4h2Wtaha6f8AC65vrKC4kiguhqCoJ41YhXxs43AA496pf8LM+Jv/AESK6/8ABmv/AMRQB22teFNP1x9Ng1Hw85i064Nta3UOoPDLDb+TnzFeNlfBZVjKZyfvHis2LwNpQubLUH8Jytd28LTpDJqsjxrPBsS3BQuUZ2XkSEErt5OTXN/8LM+Jv/RIrr/wZr/8RR/wsz4m/wDRIrr/AMGa/wDxFAHWweDdLsrfTILbwmrw6QC1jG98WVTds63akMx3BVdj82Q27C4xVe2+HPh6Oxv9IHhQjTdRmWzuWfUZHb7LGheNlYuWVPMCoI1IxnOMCua/4WZ8Tf8AokV1/wCDNf8A4ij/AIWZ8Tf+iRXX/gzX/wCIoA6TU/BGl6tqX9uX/hBm1WRDfSImqOim6gK+QrKrBGZhn5yONuDnNb+saWuo61Z6ld+H1urvTUEdpK12ANtwQlyCmcHaig/MDu6Lg155/wALM+Jv/RIrr/wZr/8AEUf8LM+Jv/RIrr/wZr/8RQB1mjeBNG0w3Nra+GpIrG8M2mzRvqUksS2bIWLpGzlUDOFXYoBGc9BUB8F6YfB+maMvg3y7PT7eW7tbePUSklvcg5WNZlYOC+5zv3YGOe1c1/wsz4m/9Eiuv/Bmv/xFH/CzPib/ANEiuv8AwZr/APEUAdxpXhq00PVkvdL8PSfabW2isILh9RaRnglnEk+d7HJRsvlss2MA10MV5qDTxq+l7I2uniZ/tCnbCFYrLjvuYKu3qN2e1eTf8LM+Jv8A0SK6/wDBmv8A8RR/wsz4m/8ARIrr/wAGa/8AxFAHqP8AaOsfZBJ/YR882TzmH7WnFwMbYM9Pmyfn6DFWJrzUElnWPS/MRJIFjb7Qo8xXYCRsdvLBLY/ixgda8m/4WZ8Tf+iRXX/gzX/4ij/hZnxN/wCiRXX/AIM1/wDiKAPWYrzUWnhR9LKRtcyRPJ9oQ7IlVikuO+4hRt6jdz0qv/aOsfYhL/YR+0fYWuPJ+1p/x8DGLfd05/v9BivLv+FmfE3/AKJFdf8AgzX/AOIo/wCFmfE3/okV1/4M1/8AiKAPWZrzUUnuFi0vzI0mhSN/tCjzEYgSPjtsBJweW28da8o8T3N38SPibb+C57GRPDuiSfbNa2ujrM4Ym2jYkdGChyoycMQcbTTG+JnxOKtt+EdyGwcE6kpAPbjZXK/DvXPiT4P0y+jk+F13qGpaheS317etqAQzSOePlIbAVcKBntnuaAPfBqGrix8z+wsXAsDceQLtP+PjHFvu6e2/pU815qKTzpHpRkjSeGON/tCjzI22+ZJg9NmW+Xq23jrXk/8Awsz4m/8ARIrr/wAGa/8AxFH/AAsz4m/9Eiuv/Bmv/wARQB6zBeai88Cy6X5cbzzRyP8AaFPlxqW8uTHffgHHVd3PSq/9o6x9jMv9hfv/ALALjyftaf8AHzjm33dOP7/SvLv+FmfE3/okV1/4M1/+Io/4WZ8Tf+iRXX/gzX/4igD1ma81FJ5Vi0syRrcxRI/2hRviYLvlx22ksNvU7eOoogvNQeeBJdL8uN5Zkkk+0KfLRWIjfHfeADgfdzz0ryb/AIWZ8Tf+iRXX/gzX/wCIo/4WZ8Tf+iRXX/gzX/4igD1EajrH2Iyf2EftH2FJxD9rT/j4Od1vu6ccfP0OasS3morPIkell41uY4lk+0KN0RVS8uO20lht6nbnvXk3/CzPib/0SK6/8Ga//EUf8LM+Jv8A0SK6/wDBmv8A8RQB6xDeai08CyaV5cbyTrI/2hT5aoxETY7+YoDY/hzg1A2o6uLJpRoZNwLOOcQ/a05nOd0G7p8uB8/Q54ry7/hZnxN/6JFdf+DNf/iKP+FmfE3/AKJFdf8AgzX/AOIoA9ZlvNRWeRE0vfELpIlk+0KN0JRS0uO21iy7ep2570iXmpNJGraVtRjcBm+0KdoR8RHHfzF+b/Z6GvJ/+FmfE3/okV1/4M1/+Io/4WZ8Tf8AokV1/wCDNf8A4igD1JtQ1cWjSDQyZxaRTCL7WnMzE74c/wCwADu6HPHSp5LvUFuGRNMLRC7WESeeozCYwxmx7OSm3qduehryb/hZnxN/6JFdf+DNf/iKP+FmfE3/AKJFdf8AgzX/AOIoA9XivdTYx79IKbhPu/0lDtKNiL6+Yvzf7PQ1GdQ1YWzSf2ITKLaGURfak5lYkSRZ6fIADu6NnjpXln/CzPib/wBEiuv/AAZr/wDEUf8ACzPib/0SK6/8Ga//ABFAHrLXeoC5KLpmYhdiESfaF5h8sMZsez5Tb14z0qOO+1RljL6OVJS4Zh9pQ7WRgIl9/MXLZ/hxg15V/wALM+Jv/RIrr/wZr/8AEUf8LM+Jv/RIrr/wZr/8RQB6o9/qqwO66KWkEEEgj+1IN0jswljz/wBMwFO7o27A6V5/rfwu0+51mW/0CwvfDWoPdrEb3R71YFeIIriZ4h8rAONmwjnJasv/AIWZ8Tf+iRXX/gzX/wCIo/4WZ8Tf+iRXX/gzX/4igDK8Fa38TPDGm6083huz8UwRahdrO9pdC3ujKhUb2QgqQy8hUBOeuOh7fw38W9I8RyyWunRrHqiiEf2dezrbXPmM371Cj4P7tSrbhkPnA5Brz/wn8QfiFa/219i+F1zdebqk8suNRUeVIduY/uc49e+ag8Yat4t8X2MttrfwRkld+VuU1FFnifGA6OEyGHGD7dxxQB6Zf6dr8vxn0bWY9Gzo8NjdafNdfao/kDGORJNmdxyylNoHHUnFS+Pr7U30nQ2l0gxyHU7eRk+0odsiXUYjjz/tgk56LjB614p4S8f/ABj8Na9DoOo+GbjWllSS6gtb+VTeCBTj/XrgNhmXJZCT2AHTovF3xD+Id1a6al78Lrm0VNStJEY6irb3WVSsf3ONxAGe2aAPUW8W6r/wsCbw/DpcMoj0i21Ax+btkV5Lho3BcnaQqgtwMnGO4rpku9QNyEbTdsJumiMnnqcQiMsJse7gJt6856V86W/jzx6Pi7e6ivw2uG1VtEigbT/t6grEJ3Il3becsSuMds12P/CzPib/ANEiuv8AwZr/APEUAepDUNXNqsh0QiY200pi+1pxKpAjiz0+cEnd0XHPWpZL3UlaQLpJYL9n2n7Qo3b3xL9PLX5v9roK8o/4WZ8Tf+iRXX/gzX/4ij/hZnxN/wCiRXX/AIM1/wDiKAPWYrzUWuFSTS9kRu2hMn2hTiERsyzY92Cpt6jdnoKgXUNXNosh0Mic2ksxi+1pxMpGyHP+2CTu6DHPWvLf+FmfE3/okV1/4M1/+Io/4WZ8Tf8AokV1/wCDNf8A4igD1iS91JZZVTSS6K1uEb7Qg3h3xKcdvLX5v9rGBSxXmotPGj6XsiN08TSfaFO2EIxWXHfcwVdvUbs9q8m/4WZ8Tf8AokV1/wCDNf8A4ij/AIWZ8Tf+iRXX/gzX/wCIoA9RGo6x9hWX+wiLg2ck5h+1pxOMbYN3T5sn5+gxzU815qKzzrHpXmRpJAsb/aFHmK7AStjt5aktj+LGBXk//CzPib/0SK6/8Ga//EUf8LM+Jv8A0SK6/wDBmv8A8RQB6zFeai08SSaXsja5kid/tCnZEFYpLjvuIUbeo3ZPSq39pax9iEv9gn7R9he4MH2tOLgY22+7pzz8/QYry/8A4WZ8Tf8AokV1/wCDNf8A4ij/AIWZ8Tf+iRXX/gzX/wCIoA9anu9QSedYtM8yNJoUjf7Qo8xGIEj47bAScdWxx1pIbzUXniWXSzHG1zLE7/aFOyJQ2yXHfcQo29Ru56GvJv8AhZnxN/6JFdf+DNf/AIij/hZnxN/6JFdf+DNf/iKAPUf7R1j7F5v9hH7R9gNx5P2tP+PjHFvu6c9N/SrE15qKTzpHpZkjSeGON/tCjzI2K+ZJjtsy3B5bbx1ryb/hZnxN/wCiRXX/AIM1/wDiK9V8Kahf6r4dsb7WNMfSr+ZN01kz7zCckYLYGfXp3oA1qKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDkvh5/zM3/AGG7n/2Wutrkvh5/zM3/AGG7n/2WutoA851P/k4HQf8AsX7v/wBHxVufET/kH6P/ANhqw/8AShK0J9R0dPF9pp0qxf29JZyTwsYcv5AdQ4D44G4rxnn8Kz/iJ/yD9H/7DVh/6UJQBoR3mhnxlPZItv8A8JGtiksjCDEv2UyMFHmY5XeG+XPB5xzW1XnNr/ycRqP/AGLFv/6VS16NQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQByXw8/5mb/sN3P/ALLXW1yXw8/5mb/sN3P/ALLXW0Aec6n/AMnA6D/2L93/AOj4q3PiJ/yD9H/7DVh/6UJVu48NQz+OLLxKbiQT2tjLYiEAbWV3RtxPXI2frVT4if8AIP0f/sNWH/pQlAFiLwysfxBufFH2olptMj077Ns4AWV5N+7PfdjGO3Wuirgba+uz8eL+xN1ObFfDkEy25kPliQ3MgLhem4gAZ64Fd9QAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQByXw8/wCZm/7Ddz/7LXW1yXw8/wCZm/7Ddz/7LXW0Aee6lcTL8eNEtxNILdtBunaIMdpYTRYJHTPvWx8RP+Qfo/8A2GrD/wBKEqlf6Nfy/GTSNZS3Y6ZDo1zbST7hhZGljZVxnPIBPTtV34if8g/R/wDsNWH/AKUJQBn2+l3y/G++1VraQac/h+G2W4x8hlFxIxTPrgg/jXdVkpe6mfFUti+mhdHWzSZL/wAwfNOXYNFs68KFbPvWtQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQByXw8/5mb/ALDdz/7LXW1yXw8/5mb/ALDdz/7LXW0AFcr8RP8AkH6P/wBhqw/9KErqq5X4if8AIP0f/sNWH/pQlAHVUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAcl8PP8AmZv+w3c/+y11tcl8PP8AmZv+w3c/+y11tABXK/ET/kH6P/2GrD/0oSuqrlfiJ/yD9H/7DVh/6UJQB1VFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHJfDz/mZv+w3c/wDstdbXJfDz/mZv+w3c/wDstdbQAVyvxE/5B+j/APYasP8A0oSuqrlfiJ/yD9H/AOw1Yf8ApQlAHVUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAcl8PP+Zm/7Ddz/wCy11tcl8PP+Zm/7Ddz/wCy11tABXK/ET/kH6P/ANhqw/8AShK6quV+In/IP0f/ALDVh/6UJQB1VFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAf//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The measurement of QT dispersion may be based either on the real QRS duration and or differences in the measurable duration of QT intervals. As shown, two hypothetical T waves of the same amplitude can have different offset when the heart vector becomes perpendicular to the axis of one of the leads; this results in real dispersion of the QT intervals (vertical dashed lines). However, if different proportion of the final part of the two T waves is below the threshold level (eg with an automatic threshold method) the measured dispersion of the QT intervals (vertical solid line) is different from the real dispersion.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_12_6336=[""].join("\n");
var outline_f6_12_6336=null;
var title_f6_12_6337="Treatment protocols for renal cell cancer";
var content_f6_12_6337=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment protocols for renal cell cancer",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/12/6337/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/12/6337/contributors\">",
"     Tim Brenner, PharmD, BCOP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/12/6337/contributors\">",
"     Shrina Duggal, PharmD, BCOP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/12/6337/contributors\">",
"     Jim Natale, PharmD, BCOP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/12/6337/contributors\">",
"     Scott M Wirth, PharmD, BCOP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/12/6337/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/12/6337/contributors\">",
"     John W Mucenski, PharmD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/12/6337/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/12/6337/contributors\">",
"     Don S Dizon, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?6/12/6337/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 18, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H12047318\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following material represents a subset of chemotherapy regimens that are used for the treatment of patients with advanced renal cell cancer.",
"    <strong>",
"     This is",
"    </strong>",
"    <strong>",
"     not an exhaustive list.",
"    </strong>",
"    Additional regimens may be added over time, particularly as treatment for renal cell cancer evolves.",
"   </p>",
"   <p>",
"    This topic review does not address the appropriate context for use of these regimens in the care of patients with renal cell cancer. Clinicians should refer to the individual disease-oriented topic reviews that discuss the use of these protocols in appropriate clinical situations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/32/28170?source=see_link&amp;anchor=H27#H27\">",
"       \"Anti-angiogenic and molecularly targeted therapy for advanced renal cell carcinoma\", section on 'Temsirolimus'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These tables are provided as examples of how to administer these regimens; there may be other acceptable methods. All protocols must be administered by clinicians who are trained in the use of chemotherapy. The clinician is expected to use his or her independent medical judgment in the context of individual circumstances to make adjustments, as necessary.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12047343\">",
"    <span class=\"h1\">",
"     REGIMENS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12047351\">",
"    <span class=\"h2\">",
"     Advanced or metastatic renal cell carcinoma",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H936667100\">",
"    <span class=\"h3\">",
"     Temsirolimus",
"    </span>",
"    &nbsp;&mdash;&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef68554 \" href=\"UTD.htm?17/4/17485\">",
"     table 1",
"    </a>",
"    )",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 85691 Version 2.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-61.234.146.186-7F4984794A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_12_6337=[""].join("\n");
var outline_f6_12_6337=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12047318\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12047343\">",
"      REGIMENS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12047351\">",
"      Advanced or metastatic renal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H936667100\">",
"      - Temsirolimus",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/85691\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/85691|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/4/17485\" title=\"table 1\">",
"      IV temsirolimus regimen",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/32/28170?source=related_link\">",
"      Anti-angiogenic and molecularly targeted therapy for advanced renal cell carcinoma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_12_6338="HS abscess";
var content_f6_12_6338=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F69605&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F69605&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hidradenitis suppurativa with an abscess",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 272px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: F William Danby, MD, FRCPC, FAAD&nbsp;and Lynne J Margesson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_12_6338=[""].join("\n");
var outline_f6_12_6338=null;
var title_f6_12_6339="Interactive diabetes case 14: A 41-year-old man with type 2 diabetes and hypertriglyceridemia";
var content_f6_12_6339=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Interactive diabetes case 14: A 41-year-old man with type 2 diabetes and hypertriglyceridemia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/12/6339/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/12/6339/contributors\">",
"     Lloyd Axelrod, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/12/6339/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/12/6339/contributors\">",
"     David M Nathan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/12/6339/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/12/6339/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?6/12/6339/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     CASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;You are asked to evaluate and manage a 41-year-old man with type 2 diabetes who was recently noted to have a triglyceride level of 1118",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    on routine lipid evaluation.",
"   </p>",
"   <p>",
"    Three years ago the patient had the following fasting laboratory values, obtained on a routine basis because of obesity: glucose 102",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (5.66",
"    <span class=\"nowrap\">",
"     mmol/L),",
"    </span>",
"    total cholesterol 209",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    triglycerides 394",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    HDL cholesterol 33",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    LDL cholesterol 116",
"    <span class=\"nowrap\">",
"     mg/dL.",
"    </span>",
"   </p>",
"   <p>",
"    Two and a half years ago, the patient had a fasting blood glucose level of 138",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (7.66",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    An A1C value a few days later was 7.1 percent. The patient was told that he has type 2 diabetes and met with a nutritionist for medical nutrition therapy.",
"   </p>",
"   <p>",
"    His efforts to reduce weight were unsuccessful despite regular visits to his clinician. Two years ago, he was started on",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    with doses titrated to 1000 mg twice a day.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/25/4503?source=see_link\">",
"     Repaglinide",
"    </a>",
"    was added soon thereafter, with doses titrated to 4 mg three times daily before meals. One month before his visit to you, his fasting laboratory values were as follows: glucose 173",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (9.6",
"    <span class=\"nowrap\">",
"     mmol/L),",
"    </span>",
"    A1C 8.9 percent, total cholesterol 231",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    triglycerides 1118",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    and HDL cholesterol 36",
"    <span class=\"nowrap\">",
"     mg/dL.",
"    </span>",
"    The LDL cholesterol was not calculated by the laboratory because these calculations are inaccurate when the triglyceride level exceeds approximately 400",
"    <span class=\"nowrap\">",
"     mg/dL.",
"    </span>",
"   </p>",
"   <p>",
"    The patient eats out in restaurants three times a week, where he has 16-ounce portions of untrimmed red meat with a baked potato. He has two eggs with two sausages for breakfast three times a week, does not drink milk, and consumes about a quarter of a pound of cheese once a week. He states that he knows he can do better with his diet and is determined to do so.",
"   </p>",
"   <p>",
"    He does not drink alcoholic beverages currently, although he acknowledges \"a drinking problem\" when he was younger, and does not smoke. He is sedentary at work and does not exercise. He has hypertension treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/37/24152?source=see_link\">",
"     ramipril",
"    </a>",
"    20 mg a day. His other medications include calcium 600 mg with vitamin D 400 Units twice daily. He has no known heart disease.",
"   </p>",
"   <p>",
"    On examination, he weighs 217 lbs and is 5 feet 5 inches tall, with a body mass index of 36.1. The blood pressure is",
"    <span class=\"nowrap\">",
"     120/80",
"    </span>",
"    right arm supine,",
"    <span class=\"nowrap\">",
"     130/90",
"    </span>",
"    right arm upright. On physical examination there is no evidence of retinopathy, neuropathy, or peripheral artery disease. The BUN is 18",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    the serum creatinine is 1.2",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    and the urine",
"    <span class=\"nowrap\">",
"     microalbumin/creatinine",
"    </span>",
"    ratio is 6.4",
"    <span class=\"nowrap\">",
"     mg/g.",
"    </span>",
"    The TSH level is 1.8",
"    <span class=\"nowrap\">",
"     microunits/dL.",
"    </span>",
"   </p>",
"   <p>",
"    You confirm in an individual discussion with the patient's wife that he no longer consumes alcoholic beverages in any amount.",
"   </p>",
"   <p>",
"    What is your assessment and plan?",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      You conclude that the patient has mixed hyperlipidemia based on the total cholesterol and triglyceride levels, and that the HDL level is below recommended values for a male patient. You conclude that he is at high risk for cardiovascular disease because of his lipid levels, diabetes, and hypertension.",
"      <br/>",
"      <br/>",
"      You advise him to limit his red meat intake to smaller portions (eg, 4 or 5 ounces), trimmed to remove the fat and consumed less frequently; to use a low fat sausage substitute and an egg substitute instead of eggs; to reduce portions at meals including those of carbohydrates; and to eliminate drinks with concentrated carbohydrates such as regular sodas and fruit juices. You encourage him to eat fish at least twice a week.",
"      <br/>",
"      <br/>",
"      You refer him to a nutritionist to review his diet. You advise him to begin walking at least five days a week, gradually increasing the duration to at least 35 minutes a day. You start him on a statin for cardiovascular risk prevention, using",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/37/35417?source=see_link\">",
"       atorvastatin",
"      </a>",
"      10 mg in the evening. You advise him to take",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      81 mg a day. You consider adding a fibric acid derivative at a later time. (See",
"      <a class=\"medical medical_answer\" href=\"UTD.htm?6/12/6339-a1?source=see_link\">",
"       \"Interactive diabetes case 14: A 41-year-old man with type 2 diabetes and hypertriglyceridemia - A1\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      You conclude that the patient probably has acute pancreatitis based on his triglyceride level. You order stat levels of amylase and lipase and a white blood count and differential count. You obtain abdominal x-rays. You ask the patient to remain in your office, anticipating admission to the hospital. (See",
"      <a class=\"medical medical_answer\" href=\"UTD.htm?6/12/6339-a2?source=see_link\">",
"       \"Interactive diabetes case 14: A 41-year-old man with type 2 diabetes and hypertriglyceridemia - A2\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      You conclude that the patient has uncontrolled diabetes and that this may be the reason for the rise in his triglyceride level over the last three years. You note that the diabetes is uncontrolled despite a prolonged trial of medical nutrition therapy and full doses of two oral agents for diabetes.",
"      <br/>",
"      <br/>",
"      You are concerned that he may have an elevation of the LDL cholesterol above recommended levels but conclude that this cannot be assessed satisfactorily until the triglyceride level has been reduced markedly.",
"      <br/>",
"      <br/>",
"      You are also concerned that the patient is at high risk for pancreatitis. You order a white blood count and differential count, and levels of amylase and lipase.",
"      <br/>",
"      <br/>",
"      You advise him to limit his red meat intake to smaller portions (eg, 4 or 5 oz), trimmed to remove the fat and consumed less frequently; to use a low fat sausage substitute and an egg substitute instead of eggs; to reduce portions at meals including those of carbohydrates; and to eliminate drinks with concentrated carbohydrates such as regular sodas and fruit juices. You encourage him to eat fish at least twice a week. You refer him to a nutritionist to review his diet.",
"      <br/>",
"      <br/>",
"      You advise him to begin walking at least five days a week, gradually increasing the duration to at least 35 minutes a day. You advise him to take",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      81 mg a day. You inform him of the risk of acute pancreatitis, a painful and life-threatening condition, if he does not reduce his triglyceride levels, and advise him of the need for close medical follow-up in the near future. (See",
"      <a class=\"medical medical_answer\" href=\"UTD.htm?6/12/6339-a3?source=see_link\">",
"       \"Interactive diabetes case 14: A 41-year-old man with type 2 diabetes and hypertriglyceridemia - A3\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?32/44/33475?source=see_link\">",
"       \"Patient information: Type 2 diabetes (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?10/48/11011?source=see_link\">",
"       \"Patient information: High cholesterol (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?9/22/9572?source=see_link\">",
"       \"Patient information: Diabetes mellitus type 2: Overview (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?40/1/40980?source=see_link\">",
"       \"Patient information: Preventing complications in diabetes mellitus (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?6/4/6212?source=see_link\">",
"       \"Patient information: High cholesterol and lipids (hyperlipidemia) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4215 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-61.234.146.186-2A6F391156-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_12_6339=[""].join("\n");
var outline_f6_12_6339=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      CASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_answer\" href=\"UTD.htm?6/12/6339-a1?source=related_link\">",
"      Interactive diabetes case 14: A 41-year-old man with type 2 diabetes and hypertriglyceridemia - A1",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_answer\" href=\"UTD.htm?6/12/6339-a2?source=related_link\">",
"      Interactive diabetes case 14: A 41-year-old man with type 2 diabetes and hypertriglyceridemia - A2",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_answer\" href=\"UTD.htm?6/12/6339-a3?source=related_link\">",
"      Interactive diabetes case 14: A 41-year-old man with type 2 diabetes and hypertriglyceridemia - A3",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?9/22/9572?source=related_link\">",
"      Patient information: Diabetes mellitus type 2: Overview (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?10/48/11011?source=related_link\">",
"      Patient information: High cholesterol (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?6/4/6212?source=related_link\">",
"      Patient information: High cholesterol and lipids (hyperlipidemia) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?40/1/40980?source=related_link\">",
"      Patient information: Preventing complications in diabetes mellitus (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?32/44/33475?source=related_link\">",
"      Patient information: Type 2 diabetes (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_12_6340="Pipingas technique for intraumbilical vein injection";
var content_f6_12_6340=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F78068&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F78068&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 547px\">",
"   <div class=\"ttl\">",
"    Pipingas technique for intraumbilical vein injection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 527px; height: 254px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The Pipingas technique. A naso-gastric tube is threaded down the umbilical vein to the placental bed, and then withdrawn by 5 cm and tied. 30 mLs of solution are then injected down the catheter.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Tim Signore.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_12_6340=[""].join("\n");
var outline_f6_12_6340=null;
var title_f6_12_6341="Insulin NPH and insulin regular: Patient drug information";
var content_f6_12_6341=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Insulin NPH and insulin regular: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/26/18855?source=see_link\">",
"     see \"Insulin NPH and insulin regular: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/46/6886?source=see_link\">",
"     see \"Insulin NPH and insulin regular: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F2137923\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      HumuLIN&reg; 70/30;",
"     </li>",
"     <li>",
"      NovoLIN&reg; 70/30",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F2186441\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Humulin&reg; 20/80;",
"     </li>",
"     <li>",
"      Humulin&reg; 70/30;",
"     </li>",
"     <li>",
"      Novolin&reg; ge 30/70;",
"     </li>",
"     <li>",
"      Novolin&reg; ge 40/60;",
"     </li>",
"     <li>",
"      Novolin&reg; ge 50/50",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10018612\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691404",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to lower blood sugar in patients with high blood sugar (diabetes).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10018611\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702304",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to insulin or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10018616\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696820",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not run out of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697009",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are 80 or older, use this drug with care. You could be more sensitive to low blood sugar.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698422",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check your blood sugar as you have been told by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698495",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have an eye exam and visit the foot doctor every year.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696750",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not drive if your blood sugar has been low. There is a greater chance of you having a crash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Limit your drinking of wine, beer, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696704",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep workouts the same. More workouts may lower your insulin needs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10018617\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698210",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Low blood sugar may occur. Signs may be dizziness, headache, feeling sleepy, feeling weak, shaking, a fast heartbeat, confusion, hunger, or sweating. Keep hard candies, glucose tablets, liquid glucose, or juice on hand for low blood sugar.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698392",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10018619\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699111",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very low blood sugar or very high blood sugar.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10018614\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699163",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use out dated insulin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2807179",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not mix this insulin in the same syringe with other types of insulin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696001",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into the fatty part of the skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695826",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take 30 minutes before a meal.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696118",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw away needles in a needle/sharp disposal box and take the box back to your doctor when it is full.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10018615\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3629482",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Give a missed shot as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3629483",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next shot, skip the missed shot and go back to your normal time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10018620\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699566",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store unopened containers in a refrigerator. Do not freeze.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3528085",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may store opened vials at room temperature or in a refrigerator. If stored at room temperature, throw away any part not used after 4 or 6 weeks as you have been told.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699656",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store opened cartridges and pens at room temperature. Throw away any part not used as you have been told by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699284",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect opened containers from heat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699285",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect opened containers from light.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10018621\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11552 Version 31.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-89.32.226.102-9F539080E8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_12_6341=[""].join("\n");
var outline_f6_12_6341=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2137923\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2186441\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018612\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018611\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018616\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018617\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018619\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018614\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018615\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018620\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018621\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?18/26/18855?source=related_link\">",
"      Insulin NPH and insulin regular: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/46/6886?source=related_link\">",
"      Insulin NPH and insulin regular: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_12_6342="Aspirin: Patient drug information";
var content_f6_12_6342=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Aspirin: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     see \"Aspirin: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/10/19624?source=see_link\">",
"     see \"Aspirin: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F137093\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Ascriptin&reg; Maximum Strength [OTC];",
"     </li>",
"     <li>",
"      Ascriptin&reg; Regular Strength [OTC];",
"     </li>",
"     <li>",
"      Aspercin [OTC];",
"     </li>",
"     <li>",
"      Aspergum&reg; [OTC];",
"     </li>",
"     <li>",
"      Aspir-low [OTC];",
"     </li>",
"     <li>",
"      Aspirtab [OTC];",
"     </li>",
"     <li>",
"      Bayer&reg; Aspirin Extra Strength [OTC];",
"     </li>",
"     <li>",
"      Bayer&reg; Aspirin Regimen Adult Low Strength [OTC];",
"     </li>",
"     <li>",
"      Bayer&reg; Aspirin Regimen Children's [OTC];",
"     </li>",
"     <li>",
"      Bayer&reg; Aspirin Regimen Regular Strength [OTC];",
"     </li>",
"     <li>",
"      Bayer&reg; Genuine Aspirin [OTC];",
"     </li>",
"     <li>",
"      Bayer&reg; Plus Extra Strength [OTC];",
"     </li>",
"     <li>",
"      Bayer&reg; Women's Low Dose Aspirin [OTC];",
"     </li>",
"     <li>",
"      Buffasal [OTC];",
"     </li>",
"     <li>",
"      Bufferin&reg; Extra Strength [OTC];",
"     </li>",
"     <li>",
"      Bufferin&reg; [OTC];",
"     </li>",
"     <li>",
"      Buffinol [OTC];",
"     </li>",
"     <li>",
"      Ecotrin&reg; Arthritis Strength [OTC];",
"     </li>",
"     <li>",
"      Ecotrin&reg; Low Strength [OTC];",
"     </li>",
"     <li>",
"      Ecotrin&reg; [OTC];",
"     </li>",
"     <li>",
"      Halfprin&reg; [OTC];",
"     </li>",
"     <li>",
"      St Joseph&reg; Adult Aspirin [OTC];",
"     </li>",
"     <li>",
"      Tri-Buffered Aspirin [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F137094\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Asaphen;",
"     </li>",
"     <li>",
"      Asaphen E.C.;",
"     </li>",
"     <li>",
"      Entrophen&reg;;",
"     </li>",
"     <li>",
"      Novasen;",
"     </li>",
"     <li>",
"      Praxis ASA EC 81 Mg Daily Dose",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10017633\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700201",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not give children and teenagers aspirin for flu signs or chickenpox.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700530",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Stent patients: Talk with your heart doctor before stopping this drug, even if told to do so by some other doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10017635\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691456",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop heart attacks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691564",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop strokes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691607",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease pain, swelling, and fever.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691733",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat arthritis.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691861",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat gout attacks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692044",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat rheumatic fever.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691573",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to protect bypass grafts and stents in the heart.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10017634\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700957",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not give to a child younger than 16 years of age for flu or chickenpox signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701553",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to aspirin or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703265",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Asthma, bleeding problems, nose polyps, or rhinitis.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701061",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are more than 24 weeks pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10017639\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697235",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have had an ulcer or bleeding from your stomach or bowel, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take good care of your teeth. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697604",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Stent patients: Talk with your heart doctor before stopping this drug for any reason.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697795",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may bleed more easily. Be careful and avoid injury. Use a soft toothbrush and an electric razor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10017640\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697889",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain or heartburn.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697901",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bleeding problems.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10017642\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699001",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Ringing in ears.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698607",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Black, tarry, or bloody stools.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698609",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Blood in the urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10017637\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695701",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swallow enteric-coated and long-acting products whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694604",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chewable tablet: Chew or crush well. Mix crushed tablet with food. Do not swallow it whole.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696199",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use suppository rectally.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10017638\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10017643\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705560",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Suppository:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699391",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a refrigerator. Do not freeze.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use suppositories if they have a vinegar smell.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10017644\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10985 Version 40.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-201.211.0.116-C984CE7589-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_12_6342=[""].join("\n");
var outline_f6_12_6342=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F137093\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F137094\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017633\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017635\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017634\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017639\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017640\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017642\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017637\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017638\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017643\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017644\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=related_link\">",
"      Aspirin: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/10/19624?source=related_link\">",
"      Aspirin: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_12_6343="Left subclavian artery GCA";
var content_f6_12_6343=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F73553&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F73553&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Narrowing of the left subclavian artery in giant cell arteritis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 406px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Angiogram of the left subclavian artery in GCA, showing several areas of severe vascular narrowing but a proliferation of small blood vessels forming excellent collateral circulation. The long, smooth arterial tapering in large-vessel GCA is often not amenable to revascularization interventions, such as angioplasty or stent placement. Those types of interventions are rarely necessary.",
"    <div class=\"footnotes\">",
"     <p>",
"      &nbsp;",
"     </p>",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of John H Stone, MD, MPH.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_12_6343=[""].join("\n");
var outline_f6_12_6343=null;
var title_f6_12_6344="Elective noncardiac surgery after percutaneous coronary intervention";
var content_f6_12_6344=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Elective noncardiac surgery after percutaneous coronary intervention",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/12/6344/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/12/6344/contributors\">",
"     Donald Cutlip, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/12/6344/contributors\">",
"     Stephan Windecker, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/12/6344/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/12/6344/contributors\">",
"     Juan Carlos Kaski, MD, DM, DSc, FRCP, FESC, FACC",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/12/6344/contributors\">",
"     Patricia A Pellikka, MD, FACC, FAHA, FASE",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/12/6344/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/12/6344/contributors\">",
"     Gordon M Saperia, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?6/12/6344/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H350961393\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of antiplatelet therapy in patients who need noncardiac surgery after percutaneous coronary intervention (PCI) with stenting requires consideration of the competing risks of acute coronary events (ACS) with premature cessation and bleeding with continuation of antiplatelet therapy. This is an important clinical problem, as it is estimated that about 5 to 10 percent of patients with coronary stents undergo noncardiac surgery within one year of stent implantation [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6344/abstract/1-4\">",
"     1-4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will focus on the approach to patients scheduled to undergo elective noncardiac surgery after PCI with stenting and who are taking dual antiplatelet therapy (DAT). Patients who require urgent or emergent surgery or those who receive balloon angioplasty are also discussed briefly. The approach to antiplatelet therapy in patients scheduled for coronary artery bypass graft surgery is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/26/40360?source=see_link&amp;anchor=H3#H3\">",
"     \"Medical therapy to prevent complications after coronary artery bypass graft surgery\", section on 'Preoperative aspirin'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/26/40360?source=see_link&amp;anchor=H6#H6\">",
"     \"Medical therapy to prevent complications after coronary artery bypass graft surgery\", section on 'Platelet P2Y12 receptor blocker therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The larger discussion of the risk of coronary artery stent thrombosis, one of the potential complications of discontinuing antiplatelet therapy prior to noncardiac surgery, is found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/24/10634?source=see_link\">",
"     \"Antiplatelet therapy after coronary artery stenting\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/59/9146?source=see_link\">",
"     \"Coronary artery stent thrombosis: Incidence and risk factors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H350963131\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;For this topic, major surgery is defined as any surgery for which the surgeon might recommend the discontinuation of dual antiplatelet therapy due to a concern for an increase in bleeding risk. Most studies that have evaluated this issue have included patients scheduled to undergo peripheral arterial, orthopedic, abdominal, or thoracic surgery, or radical prostatectomy, nephrectomy, or cystectomy.",
"   </p>",
"   <p>",
"    Dual antiplatelet therapy refers to the combination of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    plus a P2Y12 receptor blocker such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/9/34969?source=see_link\">",
"     clopidogrel",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/63/27639?source=see_link\">",
"     prasugrel",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/0/38919?source=see_link\">",
"     ticagrelor",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    Adverse perioperative outcomes include acute coronary syndromes (including myocardial infarction), death, urgent revascularization, and bleeding. In some studies, stent thrombosis is included as an outcome; stent thrombosis is often the proximate cause of myocardial infarction or death.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H350963235\">",
"    <span class=\"h1\">",
"     DEATH, MI, STENT THROMBOSIS, AND REVASCULARIZATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients taking dual antiplatelet therapy (DAT) after PCI who need to undergo noncardiac surgery, the risk of perioperative adverse cardiac events such as myocardial infarction (MI), death, stent thrombosis, and the need for urgent repeat revascularization is related to the premature cessation of DAT, the prothrombotic state created by the surgery, or an interaction between the two. Perioperative bleeding associated with the continuation of DAT is also associated with an increased risk of perioperative cardiac events.",
"   </p>",
"   <p>",
"    Observational studies suggest that patients who have undergone noncardiac surgery within six weeks after stenting may have an increased risk of death or MI [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6344/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. These events are often due to stent thrombosis, which may be caused by the premature discontinuation or reduction of antiplatelet therapy, the thrombotic risk associated with many forms of major surgery, or an interaction between the two. Stent thrombosis can lead to high rates of myocardial infarction percent (50 to 70 percent) and death (10 to 40 percent), both of which are included as components of composite outcomes in the studies discussed below [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6344/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H109480018\">",
"     'Timing and incidence'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H317413855\">",
"    <span class=\"h2\">",
"     Causes",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H350963140\">",
"    <span class=\"h3\">",
"     Premature cessation of antiplatelet therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients taking",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    and a platelet P2Y12 receptor blocker after PCI, the premature cessation of one or both agents is associated with an increase in adverse events such as stent thrombosis, myocardial infarction, or death. In fact, the premature cessation of dual antiplatelet therapy (and in particular the P2Y12 receptor blocker) is the strongest predictor of stent thrombosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/59/9146?source=see_link&amp;anchor=H10#H10\">",
"     \"Coronary artery stent thrombosis: Incidence and risk factors\", section on 'Risk factors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H350963243\">",
"    <span class=\"h3\">",
"     Prothrombotic and proinflammatory effects of surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prothrombotic and proinflammatory effects of surgery may predispose the coronary circulation to thrombosis, both at the site of prior stent placement and at other sites of atherosclerotic lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6344/abstract/9-12\">",
"     9-12",
"    </a>",
"    ]. The perioperative prothrombotic state may be mediated by increased platelet aggregation and decreased fibrinolysis [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6344/abstract/13-15\">",
"     13-15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H109480018\">",
"    <span class=\"h2\">",
"     Timing and incidence",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following observations regarding the timing and incidence of adverse outcomes following the premature discontinuation of antiplatelet therapy help inform our recommendations for managing antiplatelet therapy in patient who require noncardiac surgery:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients with stable coronary artery disease,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      is recommended indefinitely to prevent recurrent cardiovascular events and discontinuation of aspirin has been estimated to be responsible for at least 15 percent of all recurrent events in this population [",
"      <a class=\"abstract\" href=\"UTD.htm?6/12/6344/abstract/16,17\">",
"       16,17",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/12/37066?source=see_link&amp;anchor=H12#H12\">",
"       \"Benefits and risks of aspirin in secondary and primary prevention of cardiovascular disease\", section on 'Secondary prevention of CVD'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/45/40666?source=see_link&amp;anchor=H26#H26\">",
"       \"Perioperative medication management\", section on 'Aspirin'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients who have received either bare-metal (BMS) or drug-eluting stents (DES) receive dual antiplatelet therapy to prevent coronary artery stent thrombosis. Most cases of ST occur within the first 30 days after placement, irrespective of stent type. The cumulative rate of ST is similar for both bare metal and most drug-eluting stents at up to five years. At one year, the cumulative incidence is slightly greater than one percent. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/59/9146?source=see_link&amp;anchor=H4#H4\">",
"       \"Coronary artery stent thrombosis: Incidence and risk factors\", section on 'Timing and incidence'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      As mentioned above, premature cessation of dual antiplatelet therapy is the major predictor of stent thrombosis, irrespective of stent type. The risk has been estimated to be 30- to 50-fold or greater. In patients who stop both agents, stent thrombosis generally occurs within 10 days in the majority of patients who develop this complication. For those patients who stop only the platelet P2Y12 receptor blocker, the median time to ST is in excess of 100 days. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/59/9146?source=see_link&amp;anchor=H11#H11\">",
"       \"Coronary artery stent thrombosis: Incidence and risk factors\", section on 'Early and late stent thrombosis'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/59/9146?source=see_link&amp;anchor=H4#H4\">",
"       \"Coronary artery stent thrombosis: Incidence and risk factors\", section on 'Timing and incidence'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/24/10634?source=see_link&amp;anchor=H2429024#H2429024\">",
"       \"Antiplatelet therapy after coronary artery stenting\", section on 'Drug-eluting stents'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Observational studies have shown that patients who undergo major noncardiac surgery within six weeks, and particularly within two weeks, of PCI with bare-metal (BMS) or drug-eluting stents (DES) have an increased risk of adverse cardiovascular events [",
"      <a class=\"abstract\" href=\"UTD.htm?6/12/6344/abstract/1,5-7,18,19\">",
"       1,5-7,18,19",
"      </a>",
"      ]. This increased risk extends for as long as six months after DES placement. These events are often due to stent thrombosis, which may be caused by the premature discontinuation or reduction of antiplatelet therapy to minimize bleeding risk, the thrombotic risk associated with many forms of major surgery, or an interaction between the two.",
"     </li>",
"     <li>",
"      The best evidence of the risk of cardiovascular events in patients who have received an intracoronary stent and who are undergoing noncardiac surgery come from a cohort study of 8116 patients who underwent intermediate-to-high-risk elective noncardiac surgery in Ontario, Canada and received coronary stents within 10 years before surgery [",
"      <a class=\"abstract\" href=\"UTD.htm?6/12/6344/abstract/20\">",
"       20",
"      </a>",
"      ]. Of these, 34 percent underwent PCI within two years before surgery and DES were used in 33 percent. Outcomes were analyzed by stent type and time from surgery and were compared to 341,550 surgical patients who had not received PCI. While the rates of preoperative platelet P2Y12 receptor blocker were assessed (use varied between 37 and 90 percent depending on the type of stent used and the time interval between PCI and surgery), analyses were not performed based whether the drug was discontinued or not. The primary outcome was 30-day composite of mortality, readmission for acute coronary syndrome, or repeat revascularization.",
"      <br/>",
"      <br/>",
"      The following findings were noted:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For the 8116 surgical patients who underwent PCI within 10 years, the primary outcome occurred in 2.1 percent. This rate was comparable to that of intermediate risk individuals who had never received PCI. Intermediate risk was defined using the Revised Cardiac Risk Index [",
"      <a class=\"abstract\" href=\"UTD.htm?6/12/6344/abstract/19\">",
"       19",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36810?source=see_link&amp;anchor=H21#H21\">",
"       \"Estimation of cardiac risk prior to noncardiac surgery\", section on 'Revised cardiac risk index'",
"      </a>",
"      .) &nbsp;",
"     </li>",
"     <li>",
"      When the interval between stent placement and surgery was less than 45 days, the event rates for BMS and DES were very high at 6.7 and 20.0 percent respectively. Comparing these patients operated on during this time interval to those whose surgery was at least two years after PCI, the adjusted odds ratios [OR] for 30-day events 2.35, 95% CI 0.98-5.64 and 11.58, 95% CI 4.08-32.80, respectively.",
"     </li>",
"     <li>",
"      When the interval was 45 to 180 days, the event rate for BMS and DES were 2.6 and approximately 4 percent, respectively. The adjusted OR were 1.06, 95% CI 0.58-1.92 and 1.71, 95% CI 0.73-4.01, respectively.",
"     </li>",
"     <li>",
"      When the interval was 181 to 365 days, the event rate for DES was 1.2 percent (adjusted OR 0.64, 95% CI 0.20-2.04). Surprisingly, the event rate for BMS increased to about 3.5 percent during this time period, perhaps due to an increased rate of restenosis with BMS.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Smaller retrospective observational studies have evaluated the risk and timing of cardiovascular events at the time of noncardiac surgery. Conclusions from these studies are generally consistent with the findings of the Ontario study discussed above.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      In a study of 207 patients who underwent noncardiac surgery within two months of bare metal stent (BMS) placement, eight had an adverse event (death, MI, or stent thrombosis) and all occurred among the 168 patients (4.8 percent) undergoing surgery within six weeks after stenting [",
"      <a class=\"abstract\" href=\"UTD.htm?6/12/6344/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The risk of adverse events may be substantially greater when surgery is performed within two weeks of BMS placement [",
"      <a class=\"abstract\" href=\"UTD.htm?6/12/6344/abstract/5,7,18\">",
"       5,7,18",
"      </a>",
"      ]. In a report of 40 consecutive patients who underwent stent placement between one and 39 days (average 13 days) before noncardiac surgery, there were six cardiac deaths and one nonfatal MI (event rate 18 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?6/12/6344/abstract/5\">",
"       5",
"      </a>",
"      ]. There were also 11 bleeding complications, two of which were fatal. All of the cardiac complications occurred in patients who underwent surgery less than two weeks after stenting.",
"     </li>",
"     <li>",
"      In a retrospective analysis of 192 patients with either BMS or DES placed as long as two years before surgery, patients were divided into an early surgery group (30 patients), in which surgery was performed when",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/9/34969?source=see_link\">",
"       clopidogrel",
"      </a>",
"      was still indicated according to labeling criteria, or a late surgery group (162 patients) [",
"      <a class=\"abstract\" href=\"UTD.htm?6/12/6344/abstract/18\">",
"       18",
"      </a>",
"      ]. During the first 30 days after surgery, five patients (2.6 percent) died, four of whom had documented coronary artery stent thrombosis. In 91 patients (47 percent), antiplatelet therapy was interrupted in the perioperative period and was associated with a significantly higher death rate compared to those who continued therapy (5.5 versus 0 percent). Four of the deaths occurred in the early surgery group and one in the late surgery group. Within the early surgery group, 13 patients discontinued antiplatelet therapy, four of whom died. Within the late surgery group, it could not be determined whether clopidogrel was stopped in the one patient who died.",
"     </li>",
"     <li>",
"      In a study of 1953 patients who received either BMS or DES and subsequently underwent noncardiac surgery, there was no significant difference in the rate of in-hospital mortality or ischemic cardiac events between the two types of stents (13.3 versus 14.6 percent, respectively) [",
"      <a class=\"abstract\" href=\"UTD.htm?6/12/6344/abstract/1\">",
"       1",
"      </a>",
"      ]. These events occurred more frequently when surgery was performed within 42 days of stent implantation (42 versus 13 percent beyond 42 days) and when PCI had been performed in the setting of an acute coronary syndrome (65 versus 32 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Despite the general consistency of the results of these four studies with the Ontario study, they are limited by their small size, single center design, the use of less complete and potentially less accurate data, and inclusion of emergency cases in at least one study.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H350963390\">",
"    <span class=\"h1\">",
"     BLEEDING",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of a serious complication related to perioperative bleeding in patients taking one or two antiplatelet agents is not well studied, except in patients undergoing coronary artery bypass graft surgery (CABG). In these patients preoperative dual antiplatelet therapy increases that rate of bleeding as well as the need for reoperation and transfusion. Given concerns for the need for reoperation, discontinuation of P2Y12 receptor blocker at least five days before surgery is recommended. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/25/35226?source=see_link&amp;anchor=H8#H8\">",
"     \"Early noncardiac complications of coronary artery bypass graft surgery\", section on 'Bleeding'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For non-CABG surgical patients,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    alone or with P2Y12 receptor blocker increases the risk of bleeding by as much as 20 and 50 percent, respectively, and these rates are dependent on the location of the surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6344/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. This excess bleeding leads to an increase in red blood cell transfusion, but not to an increase in surgical mortality or morbidity. &nbsp;",
"   </p>",
"   <p>",
"    Despite the lack of definitive evidence of an increase in surgical mortality or morbidity in patients taking dual antiplatelet therapy, many surgeons recommend discontinuing P2Y12 receptor blocker before surgery. In some situations such as neurosurgery, where the consequence of bleeding might be catastrophic, both",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    and P2Y12 therapy are stopped.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H350963316\">",
"    <span class=\"h1\">",
"     OUR APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following discussion applies to patients scheduled to undergo noncardiac surgery for whom it may be necessary to stop one or both antiplatelet agents prior the recommended duration of such therapy. For these patients, we and others believe that recommendations regarding the optimal timing of elective noncardiac surgery after PCI with stenting as well as the optimal use of antiplatelet therapy are based on low quality evidence [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6344/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The use of DAT should be made on a case by case basis, taking into account the relative benefits and risks of continuing such therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6344/abstract/24\">",
"     24",
"    </a>",
"    ]. Prior to surgery, the patient, primary care physician, cardiologist, anesthesiologist, and surgeon should be involved in decision making.",
"   </p>",
"   <p>",
"    It should be kept in mind that the required duration of treatment with DAT for the general population of patients who have undergone coronary stenting is much shorter for BMS than DES, presumably due to the much shorter time required for endothelialization of the stent with the former. Thus, DAT is recommended for at one least month after BMS and for at least six months (or up to one year in patients not at high risk of bleeding) after DES. When possible, we suggest continuation of DAT for one year after both types of stents. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/24/10634?source=see_link&amp;anchor=H18#H18\">",
"     \"Antiplatelet therapy after coronary artery stenting\", section on 'Summary and recommendations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H350963808\">",
"    <span class=\"h2\">",
"     Elective noncardiac surgery in stented patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;In order to minimize adverse cardiovascular events, we suggest that elective noncardiac surgery be deferred until after the minimal recommended duration of dual antiplatelet therapy (DAT) for each type of stent. For patients treated with either bare metal or drug-eluting stents who are not at high risk of bleeding, we suggest one year of dual antiplatelet therapy. In patients at high risk of bleeding, our recommended duration of therapy is one and six months, respectively. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/24/10634?source=see_link&amp;anchor=H11#H11\">",
"     \"Antiplatelet therapy after coronary artery stenting\", section on 'Early noncardiac surgery or gastrointestinal endoscopy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    While the optimal duration of dual antiplatelet therapy for stented patients is not known, we are concerned that the proinflammatory and prothrombotic risks of surgery may increase the baseline risk of stent thrombosis even in the presence of DAT if a significant percent of struts are not endothelialized. In addition, one cannot predict the possibility that DAT might have to be stopped due to unexpected major bleeding. Thus, we recommend caution in performing elective noncardiac surgery prior to the minimal recommended duration of such therapy. Although the minimal duration of such therapy is four weeks for BMS, we recommend waiting six weeks given our concerns about the possible increased risk of stent thrombosis in the perioperative period.",
"   </p>",
"   <p>",
"    The final decision to continue or discontinue antiplatelet therapy in the perioperative period should be made only after an informed discussion among the surgeon, managing cardiologist (and other health care providers), and the patient has taken place. Some surgeons are not fully aware of the risk of prematurely discontinuing antiplatelet therapy in patients with recent PCI with stenting. In many cases, DAT can be continued in the perioperative period, although for some surgeries such as neurosurgery, posterior eye surgery, or prostatic surgery, the risk of major bleeding may be greater than the risk of stent thrombosis.",
"   </p>",
"   <p>",
"    Our recommendations for the timing of surgery are based on observations presented above regarding the rates of stent thrombosis in patients with premature cessation of DAT and rates of adverse cardiovascular events found in studies of patients undergoing noncardiac surgery. (See",
"    <a class=\"local\" href=\"#H109480018\">",
"     'Timing and incidence'",
"    </a>",
"    above.) No randomized trials comparing different times for surgery after PCI or differing antiplatelet strategies have been performed. These recommendations attempt to take into account what is known about the risk of perioperative bleeding on one or two antiplatelet agents.",
"   </p>",
"   <p>",
"    If surgery must be performed before the minimum time period for dual antiplatelet therapy (generally one year in patients not at high bleeding risk), we suggest that an attempt be made to defer it for at least six weeks after placement of a bare-metal stent and at least six months after a drug-eluting stent. In these patients, a platelet P2Y12 receptor blocker should be discontinued for as brief a period as possible.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     Aspirin",
"    </a>",
"    should be continued through the perioperative period, since the risk of stent thrombosis is further increased with the cessation of both aspirin and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/9/34969?source=see_link\">",
"     clopidogrel",
"    </a>",
"    and surgery can usually be safely performed on aspirin. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/45/40666?source=see_link&amp;anchor=H26#H26\">",
"     \"Perioperative medication management\", section on 'Aspirin'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Additional points to consider include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Minor surgical procedures and dental procedures do not require cessation of antiplatelet therapy.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/9/34969?source=see_link\">",
"       Clopidogrel",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?26/63/27639?source=see_link\">",
"       prasugrel",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/0/38919?source=see_link\">",
"       ticagrelor",
"      </a>",
"      should be stopped five, seven, and three days before surgery. Some experts are willing to recommend shorter discontinuation periods, for procedures less likely to be associated with major bleeding.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/9/34969?source=see_link\">",
"       Clopidogrel",
"      </a>",
"      , if stopped, should be restarted with a loading dose of 300 mg as soon as possible after surgery, perhaps even later in the day if postoperative bleeding has stopped. Some experts recommend a higher loading dose of 600 mg to decrease time to effectiveness in the higher risk postoperative setting [",
"      <a class=\"abstract\" href=\"UTD.htm?6/12/6344/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      We suggest that surgery be performed in centers with 24-hour interventional cardiology coverage [",
"      <a class=\"abstract\" href=\"UTD.htm?6/12/6344/abstract/25\">",
"       25",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/45/29402?source=see_link&amp;anchor=H9#H9\">",
"       \"Management of cardiac risk for noncardiac surgery\", section on 'Preoperative PCI'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H350963815\">",
"    <span class=\"h2\">",
"     Urgent or emergent noncardiac surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients who require surgery prior to the minimal duration of dual antiplatelet therapy (DAT) discussed above, such as those who require urgent or emergent noncardiac surgery, two issues need to be discussed among all managing practitioners:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The relative risks and benefits of continuing DAT.",
"     </li>",
"     <li>",
"      Role of platelet transfusion. For patients who are at increased risk of bleeding, there will not be time to discontinue one or both antiplatelet agents. While platelet transfusion may be necessary for excessive bleeding after surgery, the role of prophylactic platelet transfusion has not been well studied. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/9/29850?source=see_link&amp;anchor=H38#H38\">",
"       \"Congenital and acquired disorders of platelet function\", section on 'Platelet transfusion'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H350964402\">",
"    <span class=\"h2\">",
"     Patients with prior balloon angioplasty",
"    </span>",
"    &nbsp;&mdash;&nbsp;Less than 5 percent of all PCIs are performed using balloon angioplasty without stenting. In these patients, one month of DAT is generally recommended. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/8/27786?source=see_link&amp;anchor=H275406809#H275406809\">",
"     \"Antithrombotic therapy for percutaneous coronary intervention: General use\", section on 'Patients undergoing balloon angioplasty'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are no high quality studies that address the optimal approach to these patients who need noncardiac surgery. If possible, we and others suggest waiting at least 14 days before performing surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6344/abstract/26\">",
"     26",
"    </a>",
"    ]. For patients who must undergo surgery in a shorter time frame, and in particular when antiplatelet therapy must be stopped (eg, neurosurgical procedures), we suggest deferring surgery for at least 48 hours after balloon angioplasty.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H350963105\">",
"    <span class=\"h1\">",
"     RECOMMENDATIONS OF OTHERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Our recommendations for patients with coronary stents undergoing noncardiac surgery are generally consistent with those from the American College of Chest Physicians, American College of Cardiology, and the European Society of Cardiology [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6344/abstract/26-29\">",
"     26-29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H350963489\">",
"    <span class=\"h1\">",
"     POTENTIAL ALTERNATIVES TO DUAL ANTIPLATELET THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The concept of bridging a gap in platelet P2Y12 receptor blocker therapy using an intravenous glycoprotein",
"    <span class=\"nowrap\">",
"     IIb/IIIa",
"    </span>",
"    inhibitor such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/2/13351?source=see_link\">",
"     tirofiban",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/24/32135?source=see_link\">",
"     eptifibatide",
"    </a>",
"    is under investigation [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6344/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. Some academic medical centers have used such a bridging strategy in patients at high risk of stent thrombosis [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6344/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/0/38919?source=see_link\">",
"     Ticagrelor",
"    </a>",
"    has a shorter clinical half life than",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/9/34969?source=see_link\">",
"     clopidogrel",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/63/27639?source=see_link\">",
"     prasugrel",
"    </a>",
"    , and can be stopped 48 to 72 hours before surgery. Its role as a substitute for these other P2Y12 receptor blockers in this setting has not been evaluated.",
"   </p>",
"   <p>",
"    Parenteral anticoagulants such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    do not decrease the risk of stent thrombosis and should not be used as a substitute to antiplatelet therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H350963112\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Noncardiac surgery is often required in patients taking dual antiplatelet therapy (DAT) after percutaneous coronary intervention (PCI) with stenting. Cessation of DAT prior to the recommended duration of its use as well as the prothrombotic and proinflammatory state associated with surgery contribute to an increased risk of adverse cardiovascular events such as stent thrombosis, myocardial infarction, or death. On the other hand, for some patients such as those undergoing neurosurgical procedures, the risk of bleeding attributable to DAT may be greater than the risk of an adverse cardiovascular event off such therapy. (See",
"      <a class=\"local\" href=\"#H350961393\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H350963235\">",
"       'Death, MI, stent thrombosis, and revascularization'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The following are our recommendations for patients taking DAT after PCI with stenting for whom elective noncardiac surgery is needed. The rationale for the durations presented below is given above (see",
"      <a class=\"local\" href=\"#H350963808\">",
"       'Elective noncardiac surgery in stented patients'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      We suggest deferring surgery for at least one year, as opposed to operating sooner, irrespective of stent type (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      In patients who cannot wait at least one year for noncardiac surgery, we recommend that an attempt be made to defer surgery for at least six weeks after placement of a bare-metal stent and at least six months after a drug-eluting stent (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      For most patients undergoing noncardiac surgery who are taking DAT after PCI with stenting because they have not reached the recommended duration of such therapy, we suggest continuing DAT, as opposed to stopping it prior to surgery (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"      <br/>",
"      <br/>",
"      In patients for whom the risk of bleeding is likely to exceed the risk of a perioperative event due to the premature cessation of DAT, it is reasonable to discontinue one antiplatelet agent. In patients for whom a bleeding complication could be catastrophic, such as patients undergoing neurosurgical, prostate, or posterior eye procedures, stopping both antiplatelet agents might be reasonable. &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      For patients taking DAT after PCI with balloon angioplasty who are scheduled to undergo elective noncardiac surgery, we suggest waiting at least 14 days after PCI (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H350964402\">",
"       'Patients with prior balloon angioplasty'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Recommendations for patients taking long-term",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      monotherapy undergoing noncardiac surgery and for patients undergoing coronary artery bypass graft surgery on DAT are found elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/45/40666?source=see_link&amp;anchor=H26#H26\">",
"       \"Perioperative medication management\", section on 'Aspirin'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/26/40360?source=see_link&amp;anchor=H3#H3\">",
"       \"Medical therapy to prevent complications after coronary artery bypass graft surgery\", section on 'Preoperative aspirin'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/26/40360?source=see_link&amp;anchor=H6#H6\">",
"       \"Medical therapy to prevent complications after coronary artery bypass graft surgery\", section on 'Platelet P2Y12 receptor blocker therapy'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6344/abstract/1\">",
"      Cruden NL, Harding SA, Flapan AD, et al. Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgery. Circ Cardiovasc Interv 2010; 3:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6344/abstract/2\">",
"      Berger PB, Kleiman NS, Pencina MJ, et al. Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry. JACC Cardiovasc Interv 2010; 3:920.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6344/abstract/3\">",
"      Gandhi NK, Abdel-Karim AR, Banerjee S, Brilakis ES. Frequency and risk of noncardiac surgery after drug-eluting stent implantation. Catheter Cardiovasc Interv 2011; 77:972.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6344/abstract/4\">",
"      Hawn MT, Graham LA, Richman JR, et al. The incidence and timing of noncardiac surgery after cardiac stent implantation. J Am Coll Surg 2012; 214:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6344/abstract/5\">",
"      Ka��uza GL, Joseph J, Lee JR, et al. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000; 35:1288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6344/abstract/6\">",
"      Wilson SH, Fasseas P, Orford JL, et al. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 2003; 42:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6344/abstract/7\">",
"      Reddy PR, Vaitkus PT. Risks of noncardiac surgery after coronary stenting. Am J Cardiol 2005; 95:755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6344/abstract/8\">",
"      Holmes DR Jr, Kereiakes DJ, Garg S, et al. Stent thrombosis. J Am Coll Cardiol 2010; 56:1357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6344/abstract/9\">",
"      Diamantis T, Tsiminikakis N, Skordylaki A, et al. Alterations of hemostasis after laparoscopic and open surgery. Hematology 2007; 12:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6344/abstract/10\">",
"      Rajagopalan S, Ford I, Bachoo P, et al. Platelet activation, myocardial ischemic events and postoperative non-response to aspirin in patients undergoing major vascular surgery. J Thromb Haemost 2007; 5:2028.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6344/abstract/11\">",
"      Li N, Astudillo R, Ivert T, Hjemdahl P. Biphasic pro-thrombotic and inflammatory responses after coronary artery bypass surgery. J Thromb Haemost 2003; 1:470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6344/abstract/12\">",
"      Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation 2005; 111:3481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6344/abstract/13\">",
"      Mahla E, Lang T, Vicenzi MN, et al. Thromboelastography for monitoring prolonged hypercoagulability after major abdominal surgery. Anesth Analg 2001; 92:572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6344/abstract/14\">",
"      Samama CM, Thiry D, Elalamy I, et al. Perioperative activation of hemostasis in vascular surgery patients. Anesthesiology 2001; 94:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6344/abstract/15\">",
"      Beving H, Zhao C, Alb&aring;ge A, Ivert T. Abnormally high platelet activity after discontinuation of acetylsalicylic acid treatment. Blood Coagul Fibrinolysis 1996; 7:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6344/abstract/16\">",
"      Ferrari E, Benhamou M, Cerboni P, Marcel B. Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis. J Am Coll Cardiol 2005; 45:456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6344/abstract/17\">",
"      Biondi-Zoccai GG, Lotrionte M, Agostoni P, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J 2006; 27:2667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6344/abstract/18\">",
"      Schouten O, van Domburg RT, Bax JJ, et al. Noncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events. J Am Coll Cardiol 2007; 49:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6344/abstract/19\">",
"      Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100:1043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6344/abstract/20\">",
"      Wijeysundera DN, Wijeysundera HC, Yun L, et al. Risk of elective major noncardiac surgery after coronary stent insertion: a population-based study. Circulation 2012; 126:1355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6344/abstract/21\">",
"      Chassot PG, Delabays A, Spahn DR. Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction. Br J Anaesth 2007; 99:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6344/abstract/22\">",
"      Burger W, Chemnitius JM, Kneissl GD, R&uuml;cker G. Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis. J Intern Med 2005; 257:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6344/abstract/23\">",
"      Singla S, Sachdeva R, Uretsky BF. The risk of adverse cardiac and bleeding events following noncardiac surgery relative to antiplatelet therapy in patients with prior percutaneous coronary intervention. J Am Coll Cardiol 2012; 60:2005.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6344/abstract/24\">",
"      Dweck MR, Cruden NL. Noncardiac surgery in patients with coronary artery stents. Arch Intern Med 2012; 172:1054.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6344/abstract/25\">",
"      Brilakis ES, Banerjee S, Berger PB. Perioperative management of patients with coronary stents. J Am Coll Cardiol 2007; 49:2145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6344/abstract/26\">",
"      Fleisher LA, Beckman JA, Brown KA, et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation 2009; 120:e169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6344/abstract/27\">",
"      Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141:e326S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6344/abstract/28\">",
"      Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 2011; 58:e44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6344/abstract/29\">",
"      Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), European Association for Percutaneous Cardiovascular Interventions (EAPCI), Wijns W, et al. Guidelines on myocardial revascularization. Eur Heart J 2010; 31:2501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6344/abstract/30\">",
"      Savonitto S, D'Urbano M, Caracciolo M, et al. Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of 'bridging' antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel. Br J Anaesth 2010; 104:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6344/abstract/31\">",
"      Rassi AN, Blackstone E, Militello MA, et al. Safety of \"bridging\" with eptifibatide for patients with coronary stents before cardiac and non-cardiac surgery. Am J Cardiol 2012; 110:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6344/abstract/32\">",
"      Huang PH, Croce KJ, Bhatt DL, Resnic FS. Recommendations for management of antiplatelet therapy in patients undergoing elective noncardiac surgery after coronary stent implantation. Crit Pathw Cardiol 2012; 11:177.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 86233 Version 1.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-210.101.131.232-9BEAA163C5-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_12_6344=[""].join("\n");
var outline_f6_12_6344=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H350963112\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H350961393\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H350963131\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H350963235\">",
"      DEATH, MI, STENT THROMBOSIS, AND REVASCULARIZATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H317413855\">",
"      Causes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H350963140\">",
"      - Premature cessation of antiplatelet therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H350963243\">",
"      - Prothrombotic and proinflammatory effects of surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H109480018\">",
"      Timing and incidence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H350963390\">",
"      BLEEDING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H350963316\">",
"      OUR APPROACH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H350963808\">",
"      Elective noncardiac surgery in stented patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H350963815\">",
"      Urgent or emergent noncardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H350964402\">",
"      Patients with prior balloon angioplasty",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H350963105\">",
"      RECOMMENDATIONS OF OTHERS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H350963489\">",
"      POTENTIAL ALTERNATIVES TO DUAL ANTIPLATELET THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H350963112\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/24/10634?source=related_link\">",
"      Antiplatelet therapy after coronary artery stenting",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/8/27786?source=related_link\">",
"      Antithrombotic therapy for percutaneous coronary intervention: General use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/12/37066?source=related_link\">",
"      Benefits and risks of aspirin in secondary and primary prevention of cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/9/29850?source=related_link\">",
"      Congenital and acquired disorders of platelet function",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/59/9146?source=related_link\">",
"      Coronary artery stent thrombosis: Incidence and risk factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/25/35226?source=related_link\">",
"      Early noncardiac complications of coronary artery bypass graft surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36810?source=related_link\">",
"      Estimation of cardiac risk prior to noncardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/45/29402?source=related_link\">",
"      Management of cardiac risk for noncardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/26/40360?source=related_link\">",
"      Medical therapy to prevent complications after coronary artery bypass graft surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/45/40666?source=related_link\">",
"      Perioperative medication management",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_12_6345="Necrotizing GN";
var content_f6_12_6345=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F53506&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F53506&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Necrotizing glomerulonephritis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 243px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrograph showing fresh segmental necrotizing lesions with bright red fibrin deposition (arrows). A necrotizing glomerulonephritis can be seen in a variety of inflammatory disorders including vasculitis and lupus nephritis. The latter has prominent immune complex deposition which is generally absent in vasculitis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal glomerulus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 253px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrograph of a normal glomerulus. There are only 1 or 2 cells per capillary tuft, the capillary lumens are open, the thickness of the glomerular capillary wall (long arrow) is similar to that of the tubular basement membranes (short arrow), and the mesangial cells and mesangial matrix are located in the central or stalk regions of the tuft (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut G Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_12_6345=[""].join("\n");
var outline_f6_12_6345=null;
var title_f6_12_6346="Overview of illicit drug use in pregnant women";
var content_f6_12_6346=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of illicit drug use in pregnant women",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/12/6346/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/12/6346/contributors\">",
"     Grace Chang, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/12/6346/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/12/6346/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/12/6346/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/12/6346/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?6/12/6346/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 22, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The obstetrical provider is in a key position for screening, early diagnosis, counseling, and initiating treatment of pregnant women who use illicit drugs",
"    <span class=\"nowrap\">",
"     (marijuana/hashish,",
"    </span>",
"    cocaine, heroin, hallucinogens, inhalants, methamphetamine, prescription psychotherapeutics used non-medically) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/1\">",
"     1",
"    </a>",
"    ]. Both the gravida and her family benefit from factual, nonjudgmental information about the maternal and fetal risks of substance use and from counseling about options for cessation. However, substance users may not seek prenatal care because of fear, guilt and shame, as well as concerns about medical and legal intervention [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/2\">",
"     2",
"    </a>",
"    ]. Opioid users may not even realize that they are pregnant if they are not planning pregnancy and misinterpret the early signs of pregnancy as opioid withdrawal symptoms (eg, nausea, vomiting, cramping). Unintended pregnancy is common in these women; in one study, 86 percent of pregnant opioid-using women reported their pregnancy was unintended [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pregnant women are typically highly motivated to modify their behavior in order to help their unborn child. In a national survey from the United States, the mean rate of pregnancy-related abstinence among users of illicit drugs was 57 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/4\">",
"     4",
"    </a>",
"    ]. Unfortunately, many of these women resumed substance use during the year after giving birth, although not to the level of nonpregnant women who were not recent mothers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following terms are used to distinguish different patterns of drug use for diagnosis and treatment (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/58/5033?source=see_link\">",
"     \"Substance use disorders: Principles for recognition and assessment in general medical care\"",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Use",
"      </strong>",
"      &mdash; Sporadic consumption of alcohol or drugs with no adverse consequences of that consumption.",
"     </li>",
"     <li>",
"      <strong>",
"       Abuse",
"      </strong>",
"      &mdash; Although the frequency of consumption of alcohol or drugs may vary, some adverse consequences of that use are experienced by the user.",
"     </li>",
"     <li>",
"      <strong>",
"       Physical dependence",
"      </strong>",
"      &mdash; A state of adaptation that is manifested by a substance class-specific withdrawal syndrome that can be produced by abrupt cessation or rapid dose reduction of a substance, or by administration of an antagonist [",
"      <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Psychological dependence",
"      </strong>",
"      &mdash; A subjective sense of a need for a specific psychoactive substance, either for its positive effects or to avoid negative effects associated with its abstinence [",
"      <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Addiction",
"      </strong>",
"      &mdash; Addiction is a primary, chronic disease of brain reward, motivation, memory and related circuitry [",
"      <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/6\">",
"       6",
"      </a>",
"      ]. Dysfunction in these circuits leads the individual to pathologically pursue reward",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      relief by substance use and other behaviors. It is characterized by inability to consistently abstain, impairment in behavioral control, craving, diminished recognition of significant problems with one&rsquo;s behaviors and interpersonal relationships, and a dysfunctional emotional response. It often involves cycles of relapse and remission.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H172227321\">",
"    <span class=\"h1\">",
"     DRUG USE IN THE UNITED STATES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Illicit drugs include",
"    <span class=\"nowrap\">",
"     marijuana/hashish,",
"    </span>",
"    cocaine (including crack), heroin, hallucinogens, inhalants, and prescription psychotherapeutics used non-medically. Results from the 2010 National Survey on Drug Use and Health, which interviewed over 67,000 civilian noninstitutionalized persons over age 12 years in the United States, revealed marijuana was the most commonly used illicit drug, followed by (in decreasing order of frequency) non-medical use of psychotherapeutics, cocaine, and hallucinogens [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/7\">",
"     7",
"    </a>",
"    ]. In the non-medical use of psychotherapeutics group, the most commonly used drugs were pain relievers, followed by tranquilizers, stimulants, and sedatives.",
"   </p>",
"   <p>",
"    When interviewed, 4.4 percent of pregnant women stated that they had used illicit substances in the past month, and a much larger proportion smoked cigarettes or drank alcohol (",
"    <a class=\"graphic graphic_table graphicRef62478 \" href=\"UTD.htm?26/25/27036\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/7\">",
"     7",
"    </a>",
"    ]. The rates of illicit drug use among pregnant women by age group were: age 15 to 17 years (16.2&nbsp;percent), age 18 to 25 years (7.4&nbsp;percent), age 26 to 44 years (1.9 percent). Many women use more than one substance [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A retrospective serial, cross-sectional analysis of a nationally representative sample of newborns with neonatal abstinence syndrome noted antepartum maternal opiate use increased from 1.19 (95% CI 1.01-1.35) to 5.63 (95% CI 4.40-6.71) per 1000 births per year from 2000 to 2009 accompanied by a substantial increase in the incidence of neonatal abstinence syndrome, from 1.20 (95% CI 1.04-1.37) to 3.39 (95% CI 3.12-3.67) per 1000 hospital births per year [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     SCREENING FOR DRUG USE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The American College of Obstetricians and Gynecologists (ACOG) and the Society of Obstetricians and Gynaecologists of Canada (SOGC) consider screening for substance abuse a part of complete obstetric care and recommend asking all pregnant women about their use of alcohol and illicit drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/9-11\">",
"     9-11",
"    </a>",
"    ]. This recommendation is based on the prevalence of substance abuse in the population, its adverse effects, and data from mostly nonrandomized studies that intervention (education, prenatal care, treatment of substance abuse) can improve some maternal and neonatal outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/12-18\">",
"     12-18",
"    </a>",
"    ]. Screening followed by intervention can be cost effective [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ideally, screening is performed at the initial prenatal visit [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/9\">",
"     9",
"    </a>",
"    ], and repeat screening is performed periodically during pregnancy (eg, each trimester). Substance users come from all socioeconomic strata, ages, and races [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/20,21\">",
"     20,21",
"    </a>",
"    ], therefore, most users will only be identified if specifically asked about the problem. In one report, a prenatal care system that did not routinely screen for substance abuse identified less than one-third of women who subsequently had a child removed from the home because of parental substance abuse [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Denial is a significant barrier to identifying these patients. Denial may exist even when the patient is directly asked about drug use or confronted with behaviors suspicious for use. Pregnant women may not admit to drug use because they have guilt about its effect on their pregnancy, and fear legal consequences, including involvement of child protection agencies and loss of custody of their children [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/23\">",
"     23",
"    </a>",
"    ]. Some states consider substance abuse during pregnancy to be child abuse and a few consider it grounds for involuntary commitment to a treatment facility [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/24\">",
"     24",
"    </a>",
"    ]. Providers should be aware of local laws and requirements, which vary widely.",
"   </p>",
"   <p>",
"    Objective screening (eg, urine testing) overcomes some of these barriers, but is more costly and has other limitations. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Laboratory testing'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H172230096\">",
"    <span class=\"h2\">",
"     Screening tools",
"    </span>",
"    &nbsp;&mdash;&nbsp;Use of validated screening tools is recommended, but the options are limited [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/9\">",
"     9",
"    </a>",
"    ]. The 4P&rsquo;s Plus Screen&copy; for substance use in pregnancy consists of questions about substance use by the patient (in the past or currently), her parents, and her partner. An affirmative response should trigger further assessment (see",
"    <a class=\"local\" href=\"#H14204097\">",
"     'Assessment of screen positive patients'",
"    </a>",
"    below). However, the 4P&rsquo;s Plus Screen&copy; is a copyrighted screening instrument that may not be reproduced in any form without permission.",
"   </p>",
"   <p>",
"    The CRAFFT Substance Abuse Screen for Adolescents and Young Adults is available for use without restriction. It has had preliminary testing among pregnant young adults and was found to be better than the medical record and the T-ACE alcohol screen for identification of prenatal substance use [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/25\">",
"     25",
"    </a>",
"    ]. Two or more positive responses to the following questions indicate the need for further assessment:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <strong>",
"       C",
"      </strong>",
"      - Have you ever ridden in a",
"      <strong>",
"       CAR",
"      </strong>",
"      driven by someone (including yourself) who was high or had been using alcohol or drugs?",
"     </li>",
"     <li>",
"      <strong>",
"       R",
"      </strong>",
"      - Do you ever use alcohol or drugs to",
"      <strong>",
"       RELAX",
"      </strong>",
"      , feel better about yourself or fit in?",
"     </li>",
"     <li>",
"      <strong>",
"       A",
"      </strong>",
"      - Do you ever use alcohol or drugs while you are by yourself or",
"      <strong>",
"       ALONE",
"      </strong>",
"      ?",
"     </li>",
"     <li>",
"      <strong>",
"       F",
"      </strong>",
"      - Do you ever",
"      <strong>",
"       FORGET",
"      </strong>",
"      things you did while using alcohol or drugs?",
"     </li>",
"     <li>",
"      <strong>",
"       F",
"      </strong>",
"      - Do your",
"      <strong>",
"       FAMILY",
"      </strong>",
"      or",
"      <strong>",
"       friends",
"      </strong>",
"      ever tell you that you should cut down on your drinking or drug use?",
"     </li>",
"     <li>",
"      <strong>",
"       T",
"      </strong>",
"      - Have you ever gotten in",
"      <strong>",
"       TROUBLE",
"      </strong>",
"      while you were using alcohol or drugs?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Screening tools are described in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/58/5033?source=see_link\">",
"     \"Substance use disorders: Principles for recognition and assessment in general medical care\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14204097\">",
"    <span class=\"h2\">",
"     Assessment of screen positive patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;A practical, effective approach for interviewing women about substance abuse is respectful and sensitive use of neutrally worded questions. It is preferable to begin with questions about lawful substances, such as cigarette smoking and alcohol, followed by questions about misuse of over-the-counter drugs, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/47/19190?source=see_link\">",
"     pseudoephedrine",
"    </a>",
"    products and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     dextromethorphan",
"    </a>",
"    products, and then use of prescription drugs (opioid analgesics, sedatives, stimulants, tranquilizers), and, finally, illegal substances (marijuana, methamphetamine, cocaine, heroin, hallucinogens, and inhalants).",
"   </p>",
"   <p>",
"    Ask about the frequency of drug use, length of the most recent pattern of use, and time of last use. It may be helpful to ask about where, when, and with whom drugs are most often used.",
"   </p>",
"   <p>",
"    When appropriate, determine the route of administration: oral, intranasal, subcutaneous injection (\"skin popping\"), or intravenous. If she has ever used a needle to inject drugs, ask about shared needles.",
"   </p>",
"   <p>",
"    For each substance, ask about the quantity used (ie, quantity of powder, unit of sale from a dealer). Terms used for drug units vary regionally, and it is helpful to be familiar with local drug slang and to ask for explanations of unfamiliar terms. The amount of money spent on a",
"    <span class=\"nowrap\">",
"     daily/weekly/monthly",
"    </span>",
"    basis for drugs may also be used to quantitate drug usage. However, information about the quantity of drug use is not helpful in determining if an individual has",
"    <span class=\"nowrap\">",
"     abuse/dependence",
"    </span>",
"    and is not likely to be accurately reported.",
"   </p>",
"   <p>",
"    Ask about participation in self-help programs such as Narcotics Anonymous (NA), prior detoxification or addiction treatment, and abstinence periods. What has been helpful in the past and what has been tried? How long was the longest period of abstinence or maintenance treatment without using illicit drugs?",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H96349768\">",
"    <span class=\"h2\">",
"     Risk factors for substance use",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following characteristics may alert obstetrical providers to an increased risk of substance abuse or dependence in women with negative responses to direct questions about drug use [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/2,4,26-29\">",
"     2,4,26-29",
"    </a>",
"    ] (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/58/5033?source=see_link\">",
"     \"Substance use disorders: Principles for recognition and assessment in general medical care\"",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Young woman (especially adolescents), unmarried women, and women with lower educational achievement",
"     </li>",
"     <li>",
"      Late initiation of prenatal care",
"     </li>",
"     <li>",
"      Multiple missed prenatal visits",
"     </li>",
"     <li>",
"      Impaired school or work performance",
"     </li>",
"     <li>",
"      A sudden change in behavior, such as somnolence, intoxication, agitation, aggression, disoriented or erratic behavior. Drug users may also exhibit symptoms of depression, including loss of interest in eating, weight loss, and sleep disturbance.",
"     </li>",
"     <li>",
"      High-risk sexual behavior or history of sexually transmitted infections. Women who are trading sex for drugs are at risk for these infections.",
"     </li>",
"     <li>",
"      Relational problems, unstable home environment",
"     </li>",
"     <li>",
"      Past obstetrical history of unexplained adverse events, such as miscarriage, growth restriction, premature birth, abruptio placentae, stillbirth, or precipitous delivery",
"     </li>",
"     <li>",
"      Children not living with the mother or involved with child protection agencies",
"     </li>",
"     <li>",
"      History of medical problems associated with drug abuse (eg, cellulitis, skin abscess, endocarditis, osteomyelitis, suspicious trauma, hepatitis, phlebitis, tuberculosis), physical signs of drug use (eg, track marks, atrophy of the nasal mucosa, erosion or perforation of the nasal septum), or physical signs of withdrawal (dilation or constriction of pupils, tachycardia, conjunctival injection, sweating, watery eyes, runny nose, slurred speech, yawning, unsteady gait)",
"     </li>",
"     <li>",
"      Poor dentition",
"     </li>",
"     <li>",
"      Poor weight gain",
"     </li>",
"     <li>",
"      Diagnosis of a mental health disorder",
"     </li>",
"     <li>",
"      Family history of substance abuse",
"     </li>",
"     <li>",
"      Encounters with law enforcement agencies because of violence or trauma, theft, or prostitution",
"     </li>",
"     <li>",
"      Having a partner who is a substance abuser. This is particularly important in female patients who are often introduced to, and supplied with, drugs by a male partner.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Laboratory testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Universal laboratory testing for evidence of drug use is not recommended because of the limitations of these tests [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/10\">",
"     10",
"    </a>",
"    ]. The use and limitations of drug tests are described in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/58/5033?source=see_link&amp;anchor=H17#H17\">",
"     \"Substance use disorders: Principles for recognition and assessment in general medical care\", section on 'Drug testing'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is no consensus among research groups regarding when drug tests should be used in pregnant women or the best method for analyzing biological samples (urine, blood, hair, saliva) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/30\">",
"     30",
"    </a>",
"    ]. Urine testing is most common. Possible clinical indications for laboratory testing in pregnancy include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Previous positive drug test",
"     </li>",
"     <li>",
"      Monitoring compliance with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"       methadone",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/53/41816?source=see_link\">",
"       buprenorphine",
"      </a>",
"      use",
"     </li>",
"     <li>",
"      Abruptio placenta",
"     </li>",
"     <li>",
"      Idiopathic preterm labor",
"     </li>",
"     <li>",
"      Idiopathic fetal growth restriction",
"     </li>",
"     <li>",
"      Frequent requests for prescription drugs of abuse",
"     </li>",
"     <li>",
"      Noncompliance with prenatal care",
"     </li>",
"     <li>",
"      Unexplained fetal demise",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Positive tests for illicit drugs can have legal and economic implications. Women should be informed of the potential ramifications of a positive test result and should give informed consent prior to testing; random testing is unethical [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/31-33\">",
"     31-33",
"    </a>",
"    ]. However, medically indicated drug testing without written consent is acceptable in women who are unconscious or show obvious signs of intoxication and need to be tested in order to provide the appropriate medical interventions. Clinicians should be aware of their state's requirements for testing and reporting drug test results.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     GENERAL PRINCIPLES OF PRENATAL CARE OF THE SUBSTANCE USER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obstetrical providers should adhere to safe prescribing practices of prescription drugs and encourage healthy behaviors. They should educate patients about",
"    <span class=\"nowrap\">",
"     maternal/fetal/neonatal",
"    </span>",
"    morbidity associated with substance use, identify substance users, and be aware of local resources for consultation and patient referral [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Substance use assessment, counseling, and support by a nonjudgmental clinician may motivate some women who use illicit drugs other than opioids to abstain. Most others and all women dependent on opioids will require referral for in-depth assessment followed by counseling and treatment. (See individual topics on specific substances of abuse: marijuana, cocaine, amphetamines, non-medical use of prescription medications, etc).",
"   </p>",
"   <p>",
"    Few randomized trials have evaluated the optimum approach to management of pregnant substance abusers [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/34-38\">",
"     34-38",
"    </a>",
"    ]. Observational studies suggest that combining treatment of substance abuse with comprehensive prenatal care can reduce the frequency of some maternal and neonatal complications of maternal substance use [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/12-18\">",
"     12-18",
"    </a>",
"    ]. Components of this care should be individualized based on patient-specific factors, and may include the following [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/2,9,10,39\">",
"     2,9,10,39",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Counsel about the risks associated with each drug the mother is using. Both maternal and short- and long-term effects on offspring should be discussed.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      (See",
"      <a class=\"local\" href=\"#H96352822\">",
"       'Pregnancy complications associated with selected drugs'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/12/32970?source=see_link\">",
"       \"Cocaine abuse and dependence in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/44/3784?source=see_link\">",
"       \"Opioid abuse and dependence: Overview and patient evaluation\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/28/4554?source=see_link\">",
"       \"Cannabis use disorders: Treatment, prognosis, and long-term medical effects\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/24/22920?source=see_link\">",
"       \"Methamphetamine abuse and dependence: Epidemiology, clinical manifestations, course, assessment, and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/4/28746?source=see_link\">",
"       \"Infants of mothers with substance abuse\"",
"      </a>",
"      .) &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Encourage the patient to moderate and, ideally, discontinue use of illicit drugs; however, this depends on the specific drug and pattern of use.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For women with opiate dependence, switching to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"       methadone",
"      </a>",
"      is preferable to detoxification, as it is safer and more successful.",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/53/41816?source=see_link\">",
"       Buprenorphine",
"      </a>",
"      is another option when opiate substitution therapy is under consideration [",
"      <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/40\">",
"       40",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/29/4570?source=see_link\">",
"       \"Methadone maintenance therapy during pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Women on high doses of benzodiazepines should undergo medical detoxification to minimize or prevent withdrawal symptoms. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/52/11080?source=see_link&amp;anchor=H16#H16\">",
"       \"Benzodiazepine poisoning and withdrawal\", section on 'Withdrawal'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      If available, a program for management of discontinuation of cocaine or marijuana may be useful. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/12/32970?source=see_link&amp;anchor=H35#H35\">",
"       \"Cocaine abuse and dependence in adults\", section on 'Treatment of addiction'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/28/4554?source=see_link\">",
"       \"Cannabis use disorders: Treatment, prognosis, and long-term medical effects\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/33/27160?source=see_link&amp;anchor=H415115668#H415115668\">",
"       \"Prescription drug abuse and addiction: Prevention, identification, and management\", section on 'Addressing misuse, abuse and addiction'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Identify comorbid conditions, such as psychiatric disorders and",
"      <span class=\"nowrap\">",
"       physical/sexual/emotional",
"      </span>",
"      abuse, which occur frequently in substance abusers. The interrelationships between these issues and substance use need to be addressed in caring for these patients.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/15/6393?source=see_link\">",
"       \"Intimate partner violence: Diagnosis and screening\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/54/14183?source=see_link\">",
"       \"Intimate partner violence: Intervention and patient management\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/2/29735?source=see_link\">",
"       \"Depression in pregnant women: Clinical features and consequences\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/51/2874?source=see_link\">",
"       \"Bipolar disorder in women: Preconception and prenatal maintenance pharmacotherapy\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/16/4362?source=see_link\">",
"       \"Bipolar disorder in pregnant women: Treatment of mania, hypomania, and mixed episodes\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/22/38248?source=see_link\">",
"       \"Bipolar disorder in pregnant women: Treatment of major depression\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/37/42582?source=see_link\">",
"       \"Obsessive-compulsive disorder in pregnant and postpartum women\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Assemble a multidisciplinary team to comprehensively assess and participate in the care of these women and their offspring. The team may include obstetrical, medical, pediatric, psychiatric, addiction medicine, and social service providers.",
"     </li>",
"     <li>",
"      Address the needs of poorly nourished, homeless,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      incarcerated pregnant substance abusers. In addition to education about nutrition and weight gain, some of these women may need referral to food assistance programs and shelters, and provision of transportation vouchers and prenatal multivitamins.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/29/24023?source=see_link\">",
"       \"Pregnancy in homeless women\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/39/632?source=see_link\">",
"       \"Prenatal care for incarcerated women\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/54/19304?source=see_link\">",
"       \"Weight gain and loss in pregnancy\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/44/28362?source=see_link\">",
"       \"Nutrition in pregnancy\"",
"      </a>",
"      .)",
"      <br/>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Test for sexually transmitted diseases (eg, syphilis, gonorrhea, chlamydia, hepatitis B and C, human immunodeficiency virus) and tuberculosis, which may be transmitted to the fetus or neonate. These tests should be repeated in the third trimester in women who remain at increased risk.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/1/42010?source=see_link\">",
"       \"Initial prenatal assessment and patient education\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/48/44807?source=see_link&amp;anchor=H21417087#H21417087\">",
"       \"Prenatal care (after initial prenatal assessment)\", section on 'Sexually transmitted disease'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/61/4057?source=see_link\">",
"       \"Syphilis in pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/4/15433?source=see_link\">",
"       \"Prenatal evaluation and intrapartum management of the HIV-infected patient in resource-rich settings\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/19/26936?source=see_link\">",
"       \"Vertical transmission of hepatitis C virus\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/31/4602?source=see_link&amp;anchor=H4#H4\">",
"       \"Epidemiology, transmission, and prevention of hepatitis B virus infection\", section on 'Perinatal transmission'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/26/29096?source=see_link\">",
"       \"Tuberculosis in pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      During prenatal visits, provide education and support, monitor maternal and fetal status, and assess for complications of pregnancy or health problems related to addiction.",
"     </li>",
"     <li>",
"      Obtain an early ultrasound examination to provide the most accurate determination of gestational age, which is important for later evaluation of fetal growth and accurate diagnosis of preterm versus term or postterm gestation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/47/34553?source=see_link\">",
"       \"Prenatal assessment of gestational age\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Assess for fetal growth restriction in the second half of pregnancy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/27/23994?source=see_link\">",
"       \"Fetal growth restriction: Evaluation and management\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Perform antepartum fetal surveillance for standard obstetrical indications (eg, growth restriction, antepartum bleeding, preeclampsia) or maternal withdrawal. Substance use alone is not an indication for fetal monitoring with nonstress tests or the biophysical profile. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/26/30121?source=see_link\">",
"       \"Overview of fetal assessment\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Consult the anesthesia service prior to delivery to develop a pain management plan [",
"      <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/41,42\">",
"       41,42",
"      </a>",
"      ]. Women with substance abuse disorders, especially those involving opioids, may be more sensitive to pain, may not obtain adequate pain relief with usual doses of pain relievers, and may have difficult venous access [",
"      <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/43,44\">",
"       43,44",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Inform the pediatric service of the possibility of neonatal withdrawal. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/57/39833?source=see_link\">",
"       \"Neonatal opioid withdrawal (Neonatal abstinence syndrome)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Discuss the risks and benefits of breastfeeding. Women who use illicit drugs should understand that these drugs can be detected in breast milk and can affect the neonate. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/4/28746?source=see_link&amp;anchor=H7#H7\">",
"       \"Infants of mothers with substance abuse\", section on 'Breastfeeding'",
"      </a>",
"      .) Women on",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"       methadone",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/53/41816?source=see_link\">",
"       buprenorphine",
"      </a>",
"      may be encouraged to breastfeed; however, caution should be exercised if mothers are abusing other illicit substances",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      being treated with multiple prescription drugs. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/29/4570?source=see_link&amp;anchor=H26#H26\">",
"       \"Methadone maintenance therapy during pregnancy\", section on 'Breastfeeding'",
"      </a>",
"      .) The American Academy of Pediatrics (AAP) generally recommends against breastfeeding for women on amphetamines [",
"      <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/45\">",
"       45",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H96352822\">",
"    <span class=\"h1\">",
"     PREGNANCY COMPLICATIONS ASSOCIATED WITH SELECTED DRUGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The effect of any illicit drug on pregnancy outcome is difficult to ascertain because data are scarce and confounded by the influence of other factors, including polysubstance use, poor nutrition, poverty, co-morbid disorders, and inadequate prenatal care. In addition, reliable ascertainment of the extent of drug use during pregnancy and drug",
"    <span class=\"nowrap\">",
"     dose/purity",
"    </span>",
"    are impossible.",
"   </p>",
"   <p>",
"    The clinical manifestations of drug abuse are diverse, and differ by drug and setting (eg, usual dose, overdose, withdrawal). Combined with the physiologic changes of pregnancy and the clinical manifestations of coexisting pregnancy-related disease, diagnosis of patients presenting with serious clinical abnormalities can be challenging. For example, cocaine, heroin, and amphetamine overdose can cause hypertension and seizures, similar to",
"    <span class=\"nowrap\">",
"     preeclampsia/eclampsia.",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Opiates",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many of the medical risks associated with heroin addiction are the same for both pregnant and nonpregnant women, and similar for addiction to other opiates. In addition, opiate users typically have financial, social, and psychological problems that cause psychosocial stress, expose them to violence [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/46\">",
"     46",
"    </a>",
"    ], and affect their options and treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/44/3784?source=see_link\">",
"     \"Opioid abuse and dependence: Overview and patient evaluation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/52/29514?source=see_link\">",
"     \"Treatment of opioid abuse and dependence\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Multiple obstetrical complications have been associated with opiate-dependence in pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/47\">",
"     47",
"    </a>",
"    ]. However, it is difficult to establish the extent to which these problems are due to opiates or opiate withdrawal or other drugs used by polydrug abusers versus coexistent maternal medical, nutritional, psychological, and socioeconomic issues.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Abruptio placentae",
"     </li>",
"     <li>",
"      Fetal death",
"     </li>",
"     <li>",
"      Intraamniotic infection",
"     </li>",
"     <li>",
"      Fetal growth restriction",
"     </li>",
"     <li>",
"      Fetal passage of meconium",
"     </li>",
"     <li>",
"      Preeclampsia",
"     </li>",
"     <li>",
"      Premature labor and delivery",
"     </li>",
"     <li>",
"      Premature rupture of membranes",
"     </li>",
"     <li>",
"      Placental insufficiency",
"     </li>",
"     <li>",
"      Miscarriage",
"     </li>",
"     <li>",
"      Postpartum hemorrhage",
"     </li>",
"     <li>",
"      Septic thrombophlebitis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Neonatal outcomes, including neonatal abstinence syndrome, are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/4/28746?source=see_link&amp;anchor=H15#H15\">",
"     \"Infants of mothers with substance abuse\", section on 'Opioids'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/57/39833?source=see_link\">",
"     \"Neonatal opioid withdrawal (Neonatal abstinence syndrome)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4892499\">",
"    <span class=\"h3\">",
"     Opioid-substitution therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;For opioid-dependent women, opioid substitution therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"     methadone",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/53/41816?source=see_link\">",
"     buprenorphine",
"    </a>",
"    offers overwhelming advantages compared to continued use of heroin (eg, oral administration, known dose and purity, safe and steady availability, improved",
"    <span class=\"nowrap\">",
"     maternal/fetal/neonatal",
"    </span>",
"    outcomes). In addition, it offers a unique opportunity to bring women into medical and obstetrical care systems. Substitution therapy is preferable to medication-assisted withdrawal (detoxification) because it is safe and associated with a lower rate of resumption of heroin use [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/48,49\">",
"     48,49",
"    </a>",
"    ]. Clinical use of methadone and buprenorphine in pregnant women, as well as",
"    <span class=\"nowrap\">",
"     fetal/neonatal",
"    </span>",
"    effects, are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/29/4570?source=see_link\">",
"     \"Methadone maintenance therapy during pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/57/39833?source=see_link\">",
"     \"Neonatal opioid withdrawal (Neonatal abstinence syndrome)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/4/28746?source=see_link\">",
"     \"Infants of mothers with substance abuse\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Marijuana",
"    </span>",
"    &nbsp;&mdash;&nbsp;Marijuana is the most common illicit substance used during pregnancy. Prevalence varies according to maternal age, racial or ethnic background, and socioeconomic status. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/3/1079?source=see_link\">",
"     \"Cannabis use disorders: Epidemiology, comorbidity, and pathogenesis\"",
"    </a>",
"    .) For women under 21, however, alcohol is an &lsquo;illicit&rsquo; substance and is more commonly used than marijuana. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/38/41575?source=see_link\">",
"     \"Alcohol intake and pregnancy\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    The impact of prenatal marijuana use on pregnancy outcome is not clear. Adverse effects have not been consistently reported and there is no strong evidence of an increase in congenital anomalies or growth restriction [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/50-52\">",
"     50-52",
"    </a>",
"    ]. The findings from available studies are limited by relatively small numbers of subjects whose substance use was limited to cannabis alone.",
"   </p>",
"   <p>",
"    Observational studies have not reported an association between marijuana use and preterm birth [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/51,52\">",
"     51,52",
"    </a>",
"    ]. This finding is supported by an in vitro study in which human myometrial biopsy specimens obtained at elective term cesarean delivery were exposed to endogenous and exogenous cannabinoids [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/53\">",
"     53",
"    </a>",
"    ]. Both endogenous and exogenous cannabinoids relaxed uterine muscle, a response mediated through the cannabinoid receptor, CB1. Although this study supports the observation that use of marijuana is not associated with preterm birth, it does not address possible central, fetal, or placental effects of the drug. The cannabinoid receptor may also play a role in tubal transport and ectopic pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/54,55\">",
"     54,55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Short and long-term effects of maternal marijuana use on offspring are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/4/28746?source=see_link&amp;anchor=H19#H19\">",
"     \"Infants of mothers with substance abuse\", section on 'Marijuana'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Cocaine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Public and professional interest in prenatal cocaine use is high, although many more pregnant women smoke cigarettes, drink alcohol, or smoke marijuana than use cocaine [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/56-61\">",
"     56-61",
"    </a>",
"    ]. Female",
"    <span class=\"nowrap\">",
"     crack/cocaine",
"    </span>",
"    users in their thirties constitute a fast growing group of new users who do not use other substances. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/12/32970?source=see_link\">",
"     \"Cocaine abuse and dependence in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cocaine readily crosses the placenta and fetal blood-brain barrier; vasoconstriction is the major purported mechanism for fetal and placental damage [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/62\">",
"     62",
"    </a>",
"    ]. The putative consequences of prenatal cocaine exposure have been described in hundreds of articles. The applicability of any of the studies is limited by methodologic shortcomings, such as failure to control for maternal age, parity, socioeconomic factors, and exposure to other drugs, alcohol, and cigarettes.",
"   </p>",
"   <p>",
"    The few adequately controlled reports suggest that cocaine's effects are related to dose and stage of pregnancy. A meta-analysis including 31 studies that evaluated the relationship between maternal antenatal cocaine exposure and five adverse perinatal outcomes found cocaine use during pregnancy significantly increased the risks of [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/63\">",
"     63",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Preterm birth (OR 3.38, 95% CI 2.72-4.21)",
"     </li>",
"     <li>",
"      Low birthweight (OR 3.66, 95% CI 2.90-4.63)",
"     </li>",
"     <li>",
"      Small for gestational age infant (OR 3.23, 95% CI 2.43-4.30)",
"     </li>",
"     <li>",
"      Shorter gestational age at delivery (-1.47 week, 95% CI -1.97 to -0.98)",
"     </li>",
"     <li>",
"      Reduced birthweight (-492 grams, 95% CI -562 to -421 grams)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Others have reported increased risks of miscarriage, abruptio placentae, and decreased length (-0.71 cm) and head circumference (-0.43 cm) at birth [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/64-66\">",
"     64-66",
"    </a>",
"    ]. Teratogenic effects have not been definitively proven. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/4/28746?source=see_link&amp;anchor=H16#H16\">",
"     \"Infants of mothers with substance abuse\", section on 'Cocaine'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cardiovascular cocaine toxicity is increased in pregnant women [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/62\">",
"     62",
"    </a>",
"    ]. Cocaine toxicity usually causes hypertension, which may mimic preeclampsia. Beta-adrenergic antagonists (ie, beta blockers) should be avoided in the treatment of cocaine-related cardiovascular complications because they create unopposed alpha-adrenergic stimulation and are associated with coronary vasoconstriction and end-organ ischemia. This contraindication includes",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35544?source=see_link\">",
"     labetalol",
"    </a>",
"    , which has predominantly beta-blocking effects.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/57/15254?source=see_link\">",
"     Hydralazine",
"    </a>",
"    is preferred for treatment of hypertension in pregnant cocaine users [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/67\">",
"     67",
"    </a>",
"    ]. Decisions regarding the administration of peripartum analgesia or anesthesia need to be individualized, taking into account factors such as the combined effects of cocaine, analgesia, and anesthesia on the patient's cardiovascular and hematological status [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/68\">",
"     68",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/30/23018?source=see_link\">",
"     \"Cocaine: Acute intoxication\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/12/32970?source=see_link\">",
"     \"Cocaine abuse and dependence in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/39/39545?source=see_link\">",
"     \"Evaluation and management of the cardiovascular complications of cocaine abuse\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Amphetamines including methamphetamine",
"    </span>",
"    &nbsp;&mdash;&nbsp;A diagnosis of amphetamine abuse is becoming more common among women of reproductive age, including hospitalized pregnant women [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/69-72\">",
"     69-72",
"    </a>",
"    ]. Methamphetamine, commonly known as speed, meth, and chalk, or as ice, crystal, and glass when smoked, is a powerfully addictive stimulant. It is the drug most often produced by clandestine laboratories in the United States. About 10 million people have tried methamphetamine at some point in their lives, with abuse spreading eastward from its historic base in the west and southwest [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/73\">",
"     73",
"    </a>",
"    ]. It is a known neurotoxic agent, which damages the endings of brain cells containing dopamine.",
"   </p>",
"   <p>",
"    Amphetamines and their byproducts cross the placenta [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/74\">",
"     74",
"    </a>",
"    ]. Definitive information on the impact of exposure to methamphetamine in utero is lacking; most studies have focused on prenatal methamphetamine exposure in animal models. Amphetamines can cause hypertension and headache, suggestive of preeclampsia. Sheep studies have demonstrated that maternal administration of methamphetamine has cardiovascular and metabolic effects on the fetus (eg, increase in blood pressure, decrease in PO",
"    <sub>",
"     2",
"    </sub>",
"    and pH) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/75-77\">",
"     75-77",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    No fetal structural abnormality has been definitively associated with perinatal amphetamine exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although studies consistently report that amphetamine exposure during pregnancy is associated with an increased risk of preterm birth, low birthweight, and birth of small for gestational age infants when compared with the general obstetric population, most of these studies have not adjusted for confounding factors, such as tobacco use, polydrug exposure, nutrition, and access to prenatal care [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/79\">",
"     79",
"    </a>",
"    ]. However, a multivariate analysis that controlled for gender, maternal socioeconomic status, level of prenatal care, maternal marital status, maternal age and weight gain, and prenatal alcohol, tobacco, marijuana exposure, found that infants with prenatal methamphetamine exposure had a two-fold increased risk for intrauterine growth restriction compared to infants not exposed to methamphetamine [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/80\">",
"     80",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The Infant Development, Environment and Lifestyle study, which compared outcomes of 84 methamphetamine exposed and 1534 unexposed subjects, also reported growth restriction in exposed fetuses [",
"    <a class=\"abstract\" href=\"UTD.htm?6/12/6346/abstract/81,82\">",
"     81,82",
"    </a>",
"    ]. Methamphetamine exposure was determined by maternal self-report",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    gas chromatography-mass spectrometry confirmation of amphetamine and metabolites in infant meconium; unexposed mothers denied amphetamine use and their infants had a negative meconium screen. Mothers in both groups used prenatal alcohol, tobacco, or marijuana; mothers who used opiates, lysergic acid diethylamide (LSD), phencyclidine (PCP), or cocaine were excluded. The methamphetamine exposed group was 3.5 times more likely to be small for gestational age than the unexposed group.",
"   </p>",
"   <p>",
"    Short-term neonatal effects and long-term outcomes in offspring are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/4/28746?source=see_link&amp;anchor=H20#H20\">",
"     \"Infants of mothers with substance abuse\", section on 'Amphetamines'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H172229815\">",
"    <span class=\"h1\">",
"     RESOURCES",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <a class=\"external\" href=\"file://www.asam.org/\">",
"       American Society of Addiction Medicine",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://www.samhsa.gov/\">",
"       Substance Abuse and Mental Health Services Administration",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://www.acog.org/\">",
"       American College of Obstetrics and Gynecology",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?16/46/17122?source=see_link\">",
"       \"Patient information: Alcohol and illegal drug use in pregnancy (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Identification and treatment of women who use illicit drugs can decrease maternal drug use during pregnancy. Given the potential adverse fetal and maternal effects of drug use, we recommend screening all pregnant women for drug use (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3\">",
"       'Screening for drug use'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most practical screening method is to ask specific questions about drug use using a screening tool. Pregnant women may not admit drug use because of guilt about its effect on their pregnancy, and fear legal consequences, including loss of custody of children. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Screening for drug use'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H172230096\">",
"       'Screening tools'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Risk factors for increased likelihood of substance abuse include late initiation of prenatal care, multiple missed prenatal visits, past adverse obstetrical history, children with neurodevelopmental or behavioral problems, children not living with the mother, history of drug or alcohol mediated medical problems, substance abuse in a partner or family member, and frequent encounters with law enforcement agencies. (See",
"      <a class=\"local\" href=\"#H96349768\">",
"       'Risk factors for substance use'",
"      </a>",
"      above.) Universal laboratory testing for evidence of drug use is not recommended because of the limitations of these tests. Possible clinical indications for laboratory testing after informed consent in selected pregnant women include: previous positive drug test, monitoring compliance with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"       methadone",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/53/41816?source=see_link\">",
"       buprenorphine",
"      </a>",
"      use, unexplained abruptio placenta or fetal demise. Clinicians should be aware of their state&rsquo;s requirements for testing and reporting drug test results. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Laboratory testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Few randomized trials have evaluated the optimum approach to management of pregnant substance abusers. Observational studies suggest that combining treatment of substance abuse with comprehensive prenatal care can reduce the frequency of some maternal and neonatal complications of maternal substance use. Components of this care should be individualized based on patient-specific factors. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'General principles of prenatal care of the substance user'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For women dependent on opiates, we suggest opiate substitution treatment rather than medical detoxification or no treatment (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"       Methadone",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/53/41816?source=see_link\">",
"       buprenorphine",
"      </a>",
"      may be used; neither drug is clearly superior, but there is more experience with methadone. Methadone use is associated with fewer",
"      <span class=\"nowrap\">",
"       fetal/neonatal",
"      </span>",
"      complications and side effects than detoxification or continued use of un-prescribed opiates. (See",
"      <a class=\"local\" href=\"#H4892499\">",
"       'Opioid-substitution therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cocaine can cause vasoconstriction of uterine vessels, which is the probable major mechanism for fetal and placental injury leading to abruptio placentae, spontaneous abortion, prematurity, and fetal death. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Cocaine'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is no high quality evidence showing an adverse effect of marijuana on pregnancy outcome, but data are limited. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Marijuana'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Definitive information on the impact of exposure to methamphetamine in utero is not available. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Amphetamines including methamphetamine'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/1\">",
"      Goler NC, Armstrong MA, Taillac CJ, Osejo VM. Substance abuse treatment linked with prenatal visits improves perinatal outcomes: a new standard. J Perinatol 2008; 28:597.",
"     </a>",
"    </li>",
"    <li>",
"     Center for Substance Abuse Treatment. Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2005. (Treatment Improvement Protocol (TIP) Series, No. 43.) Chapter 13. Medication-Assisted Treatment for Opioid Addiction During Pregnancy. www.ncbi.nlm.nih.gov/books/NBK64148/ (Accessed on June 08, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/3\">",
"      Heil SH, Jones HE, Arria A, et al. Unintended pregnancy in opioid-abusing women. J Subst Abuse Treat 2011; 40:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/4\">",
"      Ebrahim SH, Gfroerer J. Pregnancy-related substance use in the United States during 1996-1998. Obstet Gynecol 2003; 101:374.",
"     </a>",
"    </li>",
"    <li>",
"     American Society of Addiction Medicine: ASAM Addiction Terminology. In: Graham, AW, Shultz, TK (Eds), Principles of Addiction Medicine, 3rd Ed, American Society of Addiction Medicine, Inc, Chevy Chase, MD 2003. p.1601.",
"    </li>",
"    <li>",
"     American Society of Addiction Medicine. Definition of addiction. file://www.asam.org/for-the-public/definition-of-addiction (Accessed on August 02, 2012).",
"    </li>",
"    <li>",
"     Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings www.samhsa.gov/data/NSDUH/2k10NSDUH/2k10Results.htm#Ch2 (Accessed on June 08, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/8\">",
"      Patrick SW, Schumacher RE, Benneyworth BD, et al. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA 2012; 307:1934.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/9\">",
"      ACOG Committee on Health Care for Underserved Women, American Society of Addiction Medicine. ACOG Committee Opinion No. 524: Opioid abuse, dependence, and addiction in pregnancy. Obstet Gynecol 2012; 119:1070.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/10\">",
"      Wong S, Ordean A, Kahan M, et al. Substance use in pregnancy. J Obstet Gynaecol Can 2011; 33:367.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Pediatrics and the American College of Obstetricians and Gynecologists. Guidelines for perinatal care, 7th ed, 2012.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/12\">",
"      Carroll, KM, Chang, G, Behr, H, et al. Improving treatment outcome in pregnant, methadone-maintained women: Results from a randomized clinical trial. Am J Addict 1995; 4:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/13\">",
"      Broekhuizen FF, Utrie J, Van Mullem C. Drug use or inadequate prenatal care? Adverse pregnancy outcome in an urban setting. Am J Obstet Gynecol 1992; 166:1747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/14\">",
"      El-Mohandes A, Herman AA, Nabil El-Khorazaty M, et al. Prenatal care reduces the impact of illicit drug use on perinatal outcomes. J Perinatol 2003; 23:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/15\">",
"      Chang G, Carroll KM, Behr HM, Kosten TR. Improving treatment outcome in pregnant opiate-dependent women. J Subst Abuse Treat 1992; 9:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/16\">",
"      Sweeney PJ, Schwartz RM, Mattis NG, Vohr B. The effect of integrating substance abuse treatment with prenatal care on birth outcome. J Perinatol 2000; 20:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/17\">",
"      Ellwood DA, Sutherland P, Kent C, O'Connor M. Maternal narcotic addiction: pregnancy outcome in patients managed by a specialized drug-dependency antenatal clinic. Aust N Z J Obstet Gynaecol 1987; 27:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/18\">",
"      Burkett G, Gomez-Marin O, Yasin SY, Martinez M. Prenatal care in cocaine-exposed pregnancies. Obstet Gynecol 1998; 92:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/19\">",
"      Goler NC, Armstrong MA, Osejo VM, et al. Early start: a cost-beneficial perinatal substance abuse program. Obstet Gynecol 2012; 119:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/20\">",
"      Chasnoff IJ, Landress HJ, Barrett ME. The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida. N Engl J Med 1990; 322:1202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/21\">",
"      Chasnoff IJ, McGourty RF, Bailey GW, et al. The 4P's Plus screen for substance use in pregnancy: clinical application and outcomes. J Perinatol 2005; 25:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/22\">",
"      Wallman CM, Smith PB, Moore K. Implementing a perinatal substance abuse screening tool. Adv Neonatal Care 2011; 11:255.",
"     </a>",
"    </li>",
"    <li>",
"     Weaver, MF. Perinatal addiction. In: Principles of addiction medicine, 3rd ed, Graham, AW, Shultz, TK (Eds), American Society of Addiction Medicine, Inc., Chevy Chase, MD 2003. p.1231.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/24\">",
"      American College of Obstetricians and Gynecologists Committee on Health Care for Underserved Women. AGOG Committee Opinion No. 473: Substance abuse reporting and pregnancy: the role of the obstetrician-gynecologist. Obstet Gynecol 2011; 117:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/25\">",
"      Chang G, Orav EJ, Jones JA, et al. Self-reported alcohol and drug use in pregnant young women: a pilot study of associated factors and identification. J Addict Med 2011; 5:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/26\">",
"      Vega WA, Kolody B, Hwang J, Noble A. Prevalence and magnitude of perinatal substance exposures in California. N Engl J Med 1993; 329:850.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/27\">",
"      Klein RF, Friedman-Campbell M, Tocco RV. History taking and substance abuse counseling with the pregnant patient. Clin Obstet Gynecol 1993; 36:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/28\">",
"      Creanga AA, Sabel JC, Ko JY, et al. Maternal drug use and its effect on neonates: a population-based study in Washington State. Obstet Gynecol 2012; 119:924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/29\">",
"      Unger AS, Martin PR, Kaltenbach K, et al. Clinical characteristics of central European and North American samples of pregnant women screened for opioid agonist treatment. Eur Addict Res 2010; 16:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/30\">",
"      Strano-Rossi S. Methods used to detect drug abuse in pregnancy: a brief review. Drug Alcohol Depend 1999; 53:257.",
"     </a>",
"    </li>",
"    <li>",
"     American College of Obstetricians and Gynecologists. Substance abuse in pregnancy. ACOG Technical Bulletin No. 195. American College of Obstetricians and Gynecologists, Washington, DC 1994.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/32\">",
"      ACOG Committee on Ethics. ACOG Committee Opinion. Number 294, May 2004. At-risk drinking and illicit drug use: ethical issues in obstetric and gynecologic practice. Obstet Gynecol 2004; 103:1021.",
"     </a>",
"    </li>",
"    <li>",
"     American College of Obstetricians and Gynecologists. Special issues in women's health. ACOG, Washington, DC 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/34\">",
"      Fischer G, Ortner R, Rohrmeister K, et al. Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study. Addiction 2006; 101:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/35\">",
"      Jones HE, O'Grady KE, Tuten M. Reinforcement-based treatment improves the maternal treatment and neonatal outcomes of pregnant patients enrolled in comprehensive care treatment. Am J Addict 2011; 20:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/36\">",
"      Schottenfeld RS, Moore B, Pantalon MV. Contingency management with community reinforcement approach or twelve-step facilitation drug counseling for cocaine dependent pregnant women or women with young children. Drug Alcohol Depend 2011; 118:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/37\">",
"      Kropp F, Winhusen T, Lewis D, et al. Increasing prenatal care and healthy behaviors in pregnant substance users. J Psychoactive Drugs 2010; 42:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/38\">",
"      Binder T, Vavrinkov&aacute; B. Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department. Neuro Endocrinol Lett 2008; 29:80.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Pediatrics, American College of Obstetricains and Gynecologists. Antepartum Care. In: Guidelines for Perinatal Care, 6th, 2007.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/40\">",
"      Alto WA, O'Connor AB. Management of women treated with buprenorphine during pregnancy. Am J Obstet Gynecol 2011; 205:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/41\">",
"      Ludlow J, Christmas T, Paech MJ, Orr B. Drug abuse and dependency during pregnancy: anaesthetic issues. Anaesth Intensive Care 2007; 35:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/42\">",
"      Kuczkowski KM. Labor analgesia for the drug abusing parturient: is there cause for concern? Obstet Gynecol Surv 2003; 58:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/43\">",
"      Cassidy B, Cyna AM. Challenges that opioid-dependent women present to the obstetric anaesthetist. Anaesth Intensive Care 2004; 32:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/44\">",
"      Meyer M, Wagner K, Benvenuto A, et al. Intrapartum and postpartum analgesia for women maintained on methadone during pregnancy. Obstet Gynecol 2007; 110:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/45\">",
"      Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics 2012; 129:e827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/46\">",
"      Bauer CR, Shankaran S, Bada HS, et al. The Maternal Lifestyle Study: drug exposure during pregnancy and short-term maternal outcomes. Am J Obstet Gynecol 2002; 186:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/47\">",
"      Kaltenbach K, Berghella V, Finnegan L. Opioid dependence during pregnancy. Effects and management. Obstet Gynecol Clin North Am 1998; 25:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/48\">",
"      Jones HE, O'Grady KE, Malfi D, Tuten M. Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes. Am J Addict 2008; 17:372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/49\">",
"      Svikis DS, Lee JH, Haug NA, Stitzer ML. Attendance incentives for outpatient treatment: effects in methadone- and nonmethadone-maintained pregnant drug dependent women. Drug Alcohol Depend 1997; 48:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/50\">",
"      Fried PA, Watkinson B, Gray R. Growth from birth to early adolescence in offspring prenatally exposed to cigarettes and marijuana. Neurotoxicol Teratol 1999; 21:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/51\">",
"      Witter FR, Niebyl JR. Marijuana use in pregnancy and pregnancy outcome. Am J Perinatol 1990; 7:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/52\">",
"      Fergusson DM, Horwood LJ, Northstone K, ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. Maternal use of cannabis and pregnancy outcome. BJOG 2002; 109:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/53\">",
"      Dennedy MC, Friel AM, Houlihan DD, et al. Cannabinoids and the human uterus during pregnancy. Am J Obstet Gynecol 2004; 190:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/54\">",
"      Wang H, Guo Y, Wang D, et al. Aberrant cannabinoid signaling impairs oviductal transport of embryos. Nat Med 2004; 10:1074.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/55\">",
"      Taylor AH, Ang C, Bell SC, Konje JC. The role of the endocannabinoid system in gametogenesis, implantation and early pregnancy. Hum Reprod Update 2007; 13:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/56\">",
"      Brunader RE, Brunader JA, Kugler JP. Prevalence of cocaine and marijuana use among pregnant women in a military health care setting. J Am Board Fam Pract 1991; 4:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/57\">",
"      George SK, Price J, Hauth JC, et al. Drug abuse screening of childbearing-age women in Alabama public health clinics. Am J Obstet Gynecol 1991; 165:924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/58\">",
"      Pegues DA, Engelgau MM, Woernle CH. Prevalence of illicit drugs detected in the urine of women of childbearing age in Alabama public health clinics. Public Health Rep 1994; 109:530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/59\">",
"      Vaughn AJ, Carzoli RP, Sanchez-Ramos L, et al. Community-wide estimation of illicit drug use in delivering women: prevalence, demographics, and associated risk factors. Obstet Gynecol 1993; 82:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/60\">",
"      Hollinshead, WH, Griffin, JF, Scott, HD, et al. Statewide prevalence of illicit drug use by pregnant women &mdash; Rhode Island. MMWR 1990; 39:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/61\">",
"      Buchi KF, Varner MW, Chase RA. The prevalence of substance abuse among pregnant women in Utah. Obstet Gynecol 1993; 81:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/62\">",
"      Plessinger MA, Woods JR Jr. Maternal, placental, and fetal pathophysiology of cocaine exposure during pregnancy. Clin Obstet Gynecol 1993; 36:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/63\">",
"      Gouin K, Murphy K, Shah PS, Knowledge Synthesis group on Determinants of Low Birth Weight and Preterm Births. Effects of cocaine use during pregnancy on low birthweight and preterm birth: systematic review and metaanalyses. Am J Obstet Gynecol 2011; 204:340.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/64\">",
"      Bada HS, Das A, Bauer CR, et al. Gestational cocaine exposure and intrauterine growth: maternal lifestyle study. Obstet Gynecol 2002; 100:916.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/65\">",
"      Richardson GA, Hamel SC, Goldschmidt L, Day NL. Growth of infants prenatally exposed to cocaine/crack: comparison of a prenatal care and a no prenatal care sample. Pediatrics 1999; 104:e18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/66\">",
"      Bandstra ES, Morrow CE, Anthony JC, et al. Intrauterine growth of full-term infants: impact of prenatal cocaine exposure. Pediatrics 2001; 108:1309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/67\">",
"      Krzysztof, M. Current opinion in obstetrics and gynecology 2007; 19:578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/68\">",
"      Kuczkowski KM. The cocaine abusing parturient: a review of anesthetic considerations. Can J Anaesth 2004; 51:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/69\">",
"      Cox S, Posner SF, Kourtis AP, Jamieson DJ. Hospitalizations with amphetamine abuse among pregnant women. Obstet Gynecol 2008; 111:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/70\">",
"      Terplan M, Smith EJ, Kozloski MJ, Pollack HA. Methamphetamine use among pregnant women. Obstet Gynecol 2009; 113:1285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/71\">",
"      American College of Obstetricians and Gynecologists Committee on Health Care for Underserved Women. Committee Opinion No. 479: Methamphetamine abuse in women of reproductive age. Obstet Gynecol 2011; 117:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/72\">",
"      Oei JL, Kingsbury A, Dhawan A, et al. Amphetamines, the pregnant woman and her children: a review. J Perinatol 2012; 32:737.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.nida.nih.gov/ResearchReports/methamph/methamph.html. (Accessed May 24, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/74\">",
"      Jones J, Rios R, Jones M, et al. Determination of amphetamine and methamphetamine in umbilical cord using liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877:3701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/75\">",
"      Stek AM, Baker RS, Fisher BK, et al. Fetal responses to maternal and fetal methamphetamine administration in sheep. Am J Obstet Gynecol 1995; 173:1592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/76\">",
"      Dickinson JE, Andres RL, Parisi VM. The ovine fetal sympathoadrenal response to the maternal administration of methamphetamine. Am J Obstet Gynecol 1994; 170:1452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/77\">",
"      Stek AM, Fisher BK, Baker RS, et al. Maternal and fetal cardiovascular responses to methamphetamine in the pregnant sheep. Am J Obstet Gynecol 1993; 169:888.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/78\">",
"      Oei JL, Kingsbury A, Dhawan A, et al. Amphetamines, the pregnant woman and her children: a review. J Perinatol 2012; 32:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/79\">",
"      Ladhani NN, Shah PS, Murphy KE, Knowledge Synthesis Group on Determinants of Preterm/LBW Births. Prenatal amphetamine exposure and birth outcomes: a systematic review and metaanalysis. Am J Obstet Gynecol 2011; 205:219.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/80\">",
"      Nguyen D, Smith LM, Lagasse LL, et al. Intrauterine growth of infants exposed to prenatal methamphetamine: results from the infant development, environment, and lifestyle study. J Pediatr 2010; 157:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/81\">",
"      Arria AM, Derauf C, Lagasse LL, et al. Methamphetamine and other substance use during pregnancy: preliminary estimates from the Infant Development, Environment, and Lifestyle (IDEAL) study. Matern Child Health J 2006; 10:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/12/6346/abstract/82\">",
"      Smith LM, LaGasse LL, Derauf C, et al. The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics 2006; 118:1149.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4799 Version 18.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-122.72.76.133-F708DC0240-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_12_6346=[""].join("\n");
var outline_f6_12_6346=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H172227321\">",
"      DRUG USE IN THE UNITED STATES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      SCREENING FOR DRUG USE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H172230096\">",
"      Screening tools",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14204097\">",
"      Assessment of screen positive patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H96349768\">",
"      Risk factors for substance use",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Laboratory testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      GENERAL PRINCIPLES OF PRENATAL CARE OF THE SUBSTANCE USER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H96352822\">",
"      PREGNANCY COMPLICATIONS ASSOCIATED WITH SELECTED DRUGS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Opiates",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4892499\">",
"      - Opioid-substitution therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Marijuana",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Cocaine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Amphetamines including methamphetamine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H172229815\">",
"      RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/4799\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/4799|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?26/25/27036\" title=\"table 1\">",
"      Prevalence of substance abuse in pregnancy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/38/41575?source=related_link\">",
"      Alcohol intake and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/52/11080?source=related_link\">",
"      Benzodiazepine poisoning and withdrawal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/22/38248?source=related_link\">",
"      Bipolar disorder in pregnant women: Treatment of major depression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/16/4362?source=related_link\">",
"      Bipolar disorder in pregnant women: Treatment of mania, hypomania, and mixed episodes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/51/2874?source=related_link\">",
"      Bipolar disorder in women: Preconception and prenatal maintenance pharmacotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/3/1079?source=related_link\">",
"      Cannabis use disorders: Epidemiology, comorbidity, and pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/28/4554?source=related_link\">",
"      Cannabis use disorders: Treatment, prognosis, and long-term medical effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/12/32970?source=related_link\">",
"      Cocaine abuse and dependence in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/30/23018?source=related_link\">",
"      Cocaine: Acute intoxication",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/2/29735?source=related_link\">",
"      Depression in pregnant women: Clinical features and consequences",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/31/4602?source=related_link\">",
"      Epidemiology, transmission, and prevention of hepatitis B virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/39/39545?source=related_link\">",
"      Evaluation and management of the cardiovascular complications of cocaine abuse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/27/23994?source=related_link\">",
"      Fetal growth restriction: Evaluation and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/4/28746?source=related_link\">",
"      Infants of mothers with substance abuse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/1/42010?source=related_link\">",
"      Initial prenatal assessment and patient education",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/15/6393?source=related_link\">",
"      Intimate partner violence: Diagnosis and screening",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/54/14183?source=related_link\">",
"      Intimate partner violence: Intervention and patient management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/29/4570?source=related_link\">",
"      Methadone maintenance therapy during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/24/22920?source=related_link\">",
"      Methamphetamine abuse and dependence: Epidemiology, clinical manifestations, course, assessment, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/57/39833?source=related_link\">",
"      Neonatal opioid withdrawal (Neonatal abstinence syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/44/28362?source=related_link\">",
"      Nutrition in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/37/42582?source=related_link\">",
"      Obsessive-compulsive disorder in pregnant and postpartum women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/44/3784?source=related_link\">",
"      Opioid abuse and dependence: Overview and patient evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/26/30121?source=related_link\">",
"      Overview of fetal assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?16/46/17122?source=related_link\">",
"      Patient information: Alcohol and illegal drug use in pregnancy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/29/24023?source=related_link\">",
"      Pregnancy in homeless women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/47/34553?source=related_link\">",
"      Prenatal assessment of gestational age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/48/44807?source=related_link\">",
"      Prenatal care (after initial prenatal assessment)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/39/632?source=related_link\">",
"      Prenatal care for incarcerated women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/4/15433?source=related_link\">",
"      Prenatal evaluation and intrapartum management of the HIV-infected patient in resource-rich settings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/33/27160?source=related_link\">",
"      Prescription drug abuse and addiction: Prevention, identification, and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/58/5033?source=related_link\">",
"      Substance use disorders: Principles for recognition and assessment in general medical care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/61/4057?source=related_link\">",
"      Syphilis in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/52/29514?source=related_link\">",
"      Treatment of opioid abuse and dependence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/26/29096?source=related_link\">",
"      Tuberculosis in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/19/26936?source=related_link\">",
"      Vertical transmission of hepatitis C virus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/54/19304?source=related_link\">",
"      Weight gain and loss in pregnancy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_12_6347="Hemodynamics kidney pregnancy";
var content_f6_12_6347=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F66445&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=11\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F66445&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=11\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Hemodynamic and renal changes during normal pregnancy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Systemic hemodynamics",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increase in cardiac output",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fall in vascular resistance and blood pressure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Blood volume expansion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Renal function and electrolyte balance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increase in glomerular filtration rate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chronic respiratory alkalosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hyponatremia due to resetting of osmostat",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increased ADH metabolism and polyuria in selected women",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_12_6347=[""].join("\n");
var outline_f6_12_6347=null;
var title_f6_12_6348="Visual behavior infants";
var content_f6_12_6348=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F73947&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F73947&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Normal visual behavior of infants",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Age, months",
"       </td>",
"       <td class=\"subtitle1\">",
"        Behavior",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        0 to 1",
"       </td>",
"       <td>",
"        Turns eyes and head to look at light sources",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Horizontal tracking",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Eye contact at 6 to 8 weeks",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        2 to 3",
"       </td>",
"       <td>",
"        Intense eye contact",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vertical and circular tracking",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Interested in mobiles",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Interested in \"lip reading\"",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"5\">",
"        3 to 6",
"       </td>",
"       <td>",
"        Watches own hands",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reaches toward, later grasps, hanging objects",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Observes toys falling and rolling away",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Shifts fixation across midline",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Visual sphere of attention widens gradually",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        7 to 10",
"       </td>",
"       <td>",
"        Notices small bread crumbs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        First touches them, then develops pincer grasp",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Interested in pictures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Recognizes partially hidden objects",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        11 to 12",
"       </td>",
"       <td>",
"        Visual orientation at home",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Looks through window and recognizes people, recognizes pictures, plays hide-and-seek",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Hyvarinen L. Assessment of visually impaired infants. Ophthalmol Clin North Am 1994; 7:219. Copyright &copy; 1994 WB Saunders.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_12_6348=[""].join("\n");
var outline_f6_12_6348=null;
var title_f6_12_6349="Psychiatric DXs in fibromyalgia";
var content_f6_12_6349=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F62023&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F62023&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Percentage of fibromyalgia (FM) patients, FM nonpatients, and healthy controls with lifetime psychiatric diagnoses",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Diagnosis",
"       </td>",
"       <td class=\"subtitle1\">",
"        FM Patients n=64",
"       </td>",
"       <td class=\"subtitle1\">",
"        FM Nonpatients n=28",
"       </td>",
"       <td class=\"subtitle1\">",
"        Healthy controls n-23",
"       </td>",
"       <td class=\"subtitle1\">",
"        P",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Anxiety disorders",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        60",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        36",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        26",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        0.008*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Simple phobia",
"       </td>",
"       <td class=\"sublist_other\">",
"        38",
"       </td>",
"       <td class=\"sublist_other\">",
"        18",
"       </td>",
"       <td class=\"sublist_other\">",
"        4",
"       </td>",
"       <td class=\"sublist_other\">",
"        0.001",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Panic disorder with agoraphobia",
"       </td>",
"       <td class=\"sublist_other\">",
"        11",
"       </td>",
"       <td class=\"sublist_other\">",
"        0",
"       </td>",
"       <td class=\"sublist_other\">",
"        0",
"       </td>",
"       <td class=\"sublist_other\">",
"        0.050",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Mood disorders",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        52",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        18",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        22",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        0.002*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Major depressive episode",
"       </td>",
"       <td class=\"sublist_other\">",
"        39",
"       </td>",
"       <td class=\"sublist_other\">",
"        11",
"       </td>",
"       <td class=\"sublist_other\">",
"        9",
"       </td>",
"       <td class=\"sublist_other\">",
"        0.001",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Major depression-recurrent episode",
"       </td>",
"       <td class=\"sublist_other\">",
"        25",
"       </td>",
"       <td class=\"sublist_other\">",
"        7",
"       </td>",
"       <td class=\"sublist_other\">",
"        4",
"       </td>",
"       <td class=\"sublist_other\">",
"        0.014",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Dysthymic disorder",
"       </td>",
"       <td class=\"sublist_other\">",
"        22",
"       </td>",
"       <td class=\"sublist_other\">",
"        7",
"       </td>",
"       <td class=\"sublist_other\">",
"        0",
"       </td>",
"       <td class=\"sublist_other\">",
"        0.004",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Bipolar disorder",
"       </td>",
"       <td class=\"sublist_other\">",
"        13",
"       </td>",
"       <td class=\"sublist_other\">",
"        4",
"       </td>",
"       <td class=\"sublist_other\">",
"        0",
"       </td>",
"       <td class=\"sublist_other\">",
"        0.043",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Body image disorders",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        34",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        14",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        4",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        0.002*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Somatization disorder",
"       </td>",
"       <td class=\"sublist_other\">",
"        23",
"       </td>",
"       <td class=\"sublist_other\">",
"        10",
"       </td>",
"       <td class=\"sublist_other\">",
"        0",
"       </td>",
"       <td class=\"sublist_other\">",
"        0.004",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Behavior/character",
"       </td>",
"       <td>",
"        27",
"       </td>",
"       <td>",
"        14",
"       </td>",
"       <td>",
"        13",
"       </td>",
"       <td>",
"        0.23",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     Probability of meeting criteria for at least one diagnosis in this category: P&lt;0.01 after Bonferroni correction, FM patients vs. controls; P&lt;0.05, FM nonpatients vs controls.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Aaron, LA, Bradley, LA, Alarc&mdash;n, GS, et al, Arthritis Rheum 1996; 39:436.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_12_6349=[""].join("\n");
var outline_f6_12_6349=null;
var title_f6_12_6350="Boy with measles";
var content_f6_12_6350=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F57803&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F57803&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Boy with measles",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 143px; height: 200px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Source: Centers for Disease Control and Prevention.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_12_6350=[""].join("\n");
var outline_f6_12_6350=null;
var title_f6_12_6351="Lg airway obstruct PFT";
var content_f6_12_6351=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F57161&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F57161&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Large airway obstruction noted on pulmonary function",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 398px; height: 461px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Flow volume loop showing flattening of the expiratory portion and normal contour to the inspiratory",
"    <br>",
"     portion (variable intra-thoracic obstruction). The curve improved after bronchoscopic treatment.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"      Reproduced with permission from: Midthun, DE, et al. Clinical presentation of lung cancer. Lung Cancer 1996; :421. Copyright &copy; Elsevier Science, Inc.",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_12_6351=[""].join("\n");
var outline_f6_12_6351=null;
